paclitaxel has been researched along with Coronary Stenosis in 327 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 179 (54.74) | 29.6817 |
2010's | 146 (44.65) | 24.3611 |
2020's | 2 (0.61) | 2.80 |
Authors | Studies |
---|---|
Ando, J; Daimon, M; Kaneko, H; Kikuchi, H; Kiriyama, H; Kiyosue, A; Kodera, S; Komuro, I; Minatsuki, S; Morita, H; Toko, H | 1 |
Chung, JH; Doh, JH; Her, AY; Koo, BK; Lee, JM; Nam, CW; Shin, ES | 1 |
Ando, K; Fujihara, M; Iida, O; Kawasaki, D; Kuramitsu, S; Soga, Y; Tomoi, Y | 1 |
Cuellas, C; Estévez, R; Fernández-Vázquez, F; López-Benito, M; Pérez de Prado, A | 1 |
Chan, CY; Fung, RC; Jim, MH; Wong, KL; Wu, EB; Yiu, KH | 1 |
Colombo, A; Giannini, F; Jabbour, RJ; Latib, A; Tanaka, A | 1 |
Bednarski, K; Bil, J; Bojko, K; Gil, RJ; Górny, J; Kern, A; Rzeszowski, B | 1 |
Baan, J; Beijk, MA; Damman, P; de Winter, RJ; Henriques, JPS; Kalkman, DN; Klomp, M; Koch, KT; Piek, JJ; Tijssen, JGP; Vis, MM; Woudstra, P | 1 |
Doh, JH; Garg, S; Her, AY; Koo, BK; Lee, JM; Nam, CW; Shin, ES | 1 |
Bossi, I; Caria, MP; Colombo, P; D'Anna, M; De Marco, F; Klugmann, S; Oliva, F; Oreglia, J; Piccalò, G; Piccaluga, E; Soriano, F; Vaccaro, V | 1 |
Chung, JH; Doh, JH; Garg, S; Her, AY; Kim, YH; Koo, BK; Lee, JM; Nam, CW; Shin, ES | 1 |
Deng, LX; Guo, WY; Hu, T; Li, JY; Li, Y; Liu, Y; Mou, FJ; Tao, L; Wang, Q; Yin, ZY; Zhang, YJ | 1 |
Abd-Alaziz, A; Bayle, S; Cerisier, A; Da Costa, A; Isaaz, K; Khamis, H; Lamaud, M; Mayaud, N; Richard, L; Robin, C; Sabry, MH | 1 |
Bourantas, C; Garg, S; Serruys, PW | 1 |
Applegate, RJ; Cristea, E; Forrest, JK; Hou, L; Kereiakes, DJ; Lansky, AJ; Meller, SM; Shah, A; Skelding, KA; Sood, P; Stone, GW; Sudhir, K; Wang, JC; Yaqub, M | 1 |
Abizaid, A; Botelho, R; Cristea, E; Den Heijer, P; Erbs, S; Haude, M; Koh, TH; Lee, SW; Maehara, A; Mehran, R; Meredith, I; Parise, H; Rosli, MA; Silber, S; Sim, KH; Stella, PR; Tan, HC; Thambar, S; Verheye, S; Whitbourn, R; Worthley, SG | 1 |
Basavarajaiah, S; Bernelli, C; Carlino, M; Chieffo, A; Colombo, A; Ferrarello, S; Figini, F; Fujino, Y; Godino, C; Hasegawa, T; Ielasi, A; Latib, A; Mizuno, H; Montorfano, M; Naganuma, T; Nakamura, S; Rezq, A; Shannon, J; Takagi, K | 1 |
Janus, M; Lesiak, M; Lukawski, K; Prech, M | 1 |
Chevalier, B; Coe, J; Cutlip, DE; Dimario, C; Grube, E; Neumann, FJ; Ormiston, J; Schwartz, LB; Whitbourn, R; Williams, DO | 1 |
Fajadet, J; Kandzari, DE; Leon, MB; Mauri, L; Meredith, I; Wijns, W | 1 |
Bae, JH; Cha, TJ; Choi, JW; Chung, WY; Hur, SH; Hyon, MS; Jeon, HK; Kang, HJ; Kang, SH; Kim, BO; Kim, DI; Kim, HS; Kim, SJ; Kim, SW; Koo, BK; Lee, HY; Lee, SG; Moon, KW; Park, JS; Park, KS; Park, KW; Seo, JB; Yang, HM; Yoo, CW; Youn, TJ | 1 |
Kutcher, MA | 2 |
Baars, T; Erbel, R; Heusch, G; Hildebrandt, HA; Kahlert, P; Kleinbongard, P | 1 |
Böhm, M; Clever, YP; Cremers, B; Dietz, U; Scheller, B; Speck, U | 1 |
Böhm, M; Clever, YP; Cremers, B; Scheller, B; Speck, U; von Scheidt, W | 1 |
Fan, KY; Fung, RC; Jim, MH; Ng, AK; Siu, CW; Yiu, KH | 1 |
Alvarez-Ossorio, MP; Bellido, FM; de Lezo Cruz-Conde, JS; de Lezo Herrerosde Tejada, JS; Fernández-Aceytuno, AM; Pavlovic, D; Pineda, SO; Romero Moreno, MÁ; Saint-Gerons, JM; Toledano Delgado, FJ | 1 |
Angioli, P; Bolognese, L; Ducci, K; Falsini, G; Grotti, S; Liistro, F; Porto, I | 1 |
Clever, YP; Cremers, B; Gershony, G; Scheller, B; Schmitmeier, S; Speck, U | 1 |
Galbraith, PD; Ghali, WA; Knudtson, ML; Leung, AA; Philpott, AC; Southern, DA | 1 |
Byrne, RA; Kastrati, A; Laugwitz, KL; Massberg, S; Mehilli, J; Schulz, S; Seyfarth, M; Tiroch, K; Vorpahl, M | 1 |
Costa, RA; Feres, F | 1 |
Hasegawa, T; Hirai, H; Nonin, S; Suehiro, S; Yoshiyama, M | 1 |
Alfonso, F; Bethencourt, A; Cárdenas, A; Cequier, A; Dominguez, A; Fernández, C; García Del Blanco, B; García-Touchard, A; Gómez-Recio, M; Gonzalo, N; Iñiguez, A; Jiménez-Quevedo, P; López-Mínguez, JR; Macaya, C; Mainar, V; Martí, V; Masotti, M; Melgares, R; Moreno, R; Moreu, J; Pérez-Vizcayno, MJ; Sanchís, J; Seidelberger, B; Velázquez, MT; Zueco, J | 1 |
Egami, Y; Makino, N; Mori, N; Nakamura, D; Nishino, M; Shutta, R; Tanaka, A; Taniike, M; Tanouchi, J; Yoshimura, T | 1 |
Egami, Y; Hamasaki, T; Hara, M; Kato, H; Lee, Y; Makino, N; Nakamura, D; Nishino, M; Sakata, Y; Shutta, R; Taniike, M; Tanouchi, J; Yamada, Y; Yoshimura, T | 1 |
Bil, J; Gil, RJ; Kulawik, T; Pawlowski, T; Rzezak, J; Vassilev, D | 1 |
Badr, S; Barbash, IM; Ben-Dor, I; Loh, JP; Minha, S; Pichard, AD; Satler, LF; Torguson, R; Waksman, R | 1 |
Chen, F; Loh, JP; Omar, A; Pendyala, LK; Pichard, AD; Satler, LF; Torguson, R; Waksman, R | 1 |
Alvarez-Contreras, L; Brugaletta, S; Cola, C; del Blanco, BG; Díaz, J; García-Picart, J; Martí, V; Martín-Yuste, V; Pinar, E; Ruiz-Salmeron, R; Sabaté, M; Shiratori, Y | 1 |
Alfonso Manterola, F; Doncel Vecino, LJ; Fernández Díaz, JA; Fernández Portales, J; González Fernández, R; López Mínguez, JR; Martínez Cáceres, G; Martínez Romero, P; Merchán Herrera, A; Nogales Asensio, JM; Romany, S; Sandoval, J | 1 |
Hino, S; Ishikawa, T; Mutoh, M; Nakano, Y; Suzuki, T | 1 |
Albertal, M; Belardi, JA | 2 |
Jerin, M; Shammas, GA; Shammas, NW; Sharis, P | 1 |
Carvalho, PO; Maranhão, RC; Stolf, NA | 1 |
Dawkins, KD; Ellis, SG; Grube, E; Kruk, M; Mandinov, L; Mintz, GS; Opolski, MP; Popma, JJ; Pracon, R; Pregowski, J; Stone, GW; Wang, H; Weissman, NJ | 1 |
Drachman, DE; Parikh, SA | 1 |
Figulla, HR; Gassdorf, J; Goebel, B; Janiak, F; Jung, C; Nitsche, K; Otto, S; Poerner, TC | 1 |
Allocco, DJ; Calabria, P; Capodanno, D; Crowley, JJ; Dawkins, KD; Erglis, A; Gilbert, TJ; Horváth, IG; Menown, IB; Moreno, R; Tamburino, C | 1 |
Ishikawa, T; Mutoh, M; Nakano, Y | 2 |
Dohi, Y; Fukuda, Y; Ikenaga, H; Ishibashi, K; Kihara, Y; Kurisu, S | 1 |
Chan, AK; Chan, KT; Fung, RC; Jim, MH; Lee, MK; Yiu, KH | 1 |
Naber, CK; Pyxaras, SA; Schmitz, T | 1 |
Berland, J | 1 |
Bil, J; Gil, RJ; Vassilev, D | 1 |
Baumgartner, S; Jüni, P; Meier, B; Räber, L; Stefanini, GG; Taniwaki, M; Wenaweser, P; Windecker, S; Zanchin, T; Zaugg, S | 1 |
Joner, M; Otsuka, F; Virmani, R; Yahagi, K | 1 |
Chibana, H; Fukumoto, Y; Ikeno, F; Itaya, N; Mitsutake, Y; Nakayoshi, T; Sasaki, K; Sasaki, M; Ueno, T; Yokoyama, S | 1 |
Boxberger, M; Buszman, PE; Buszman, PP; Gąsior, P; Gorycki, B; Granada, JF; Janas, A; Kondys, M; Michalak, M; Milewski, KP; Peppas, A; Żurakowski, A | 1 |
Bil, J; Gil, RJ; Grundeken, MJ; Iñigo Garcia, LA; Kern, A; Pawłowski, T; Serruys, PW; Vassilev, D; Wykrzykowska, JJ | 1 |
Dola, J; Kawecki, D; Marcinkiewicz, K; Morawiec, B; Nowalany-Kozielska, E; Ochała, A; Pluta, A; Smolka, G; Wańha, W; Wojakowski, W | 1 |
Buccheri, D; Cortese, B; Piraino, D | 1 |
Albert, F; Auffret, V; Barragan, P; Bedossa, M; Berland, J; Bonello, L; Carrié, D; Delarche, N; Eltchaninoff, H; Furber, A; Marcollet, P; Pansieri, M; Piot, C; Schneeberger, M; Waliszewski, M | 1 |
Boxberger, M; Degenhardt, R; Kleber, FX; Ludwig, J; Mathey, DG; Rittger, H; Scheller, B; Schulz, A; Strasser, RH | 1 |
Ann, SH; Garg, S; Her, AY; Kim, YH; Koo, BK; Shin, ES; Singh, GB; Yoo, SY | 1 |
Bai, ZG; Gao, B; Ge, B; Meng, M; Sa, RN; Wang, X | 1 |
Ann, SH; Garg, S; Her, AY; Kim, YH; Koo, BK; Okamura, T; Shin, ES; Singh, GB | 1 |
Ann, SH; Her, AY; Koo, BK; Okamura, T; Shin, ES; Singh, GB | 1 |
Hannan, EL; Qian, F; Zhong, Y | 1 |
Eccleshall, S; Ho, HH; Mok, KH; Ong, PJL; Watson, T; Wickramarachchi, U | 1 |
Farhan, S; Glogar, D; Gyöngyösi, M; Hemetsberger, R; Huber, K; Kaider, A; Khorsand, A; Matiasek, J; Pavo, N; Petneházy, O; Petrási, Z; Strehblow, C | 1 |
Chae, JK; Cho, YH; Choi, SW; Chun, KJ; Hong, MK; Jeong, JO; Kim, HS; Kim, JH; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Rhee, KS; Seong, IW; Yun, SC | 1 |
Ahn, TH; Choi, D; Han, SH; Jang, Y; Jeon, DW; Kang, WC; Kim, BK; Kim, JS; Ko, YG; Moon, CI; Oh, SJ; Shin, EK; Yang, JY | 1 |
Ahmad, M; Natarajan, MK; Pericak, D; Schwalm, JD; Velianou, JL | 2 |
Chen, J; Chen, JL; Dai, J; Gao, RL; Li, JJ; Liu, HB; Qiao, SB; Qin, XW; Wu, YJ; Xu, B; Yang, YJ; Yao, M; You, SJ; Yuan, JQ | 1 |
Ahn, MS; Cho, JR; Choi, D; Hong, BK; Jang, Y; Jeon, DW; Jung, JH; Kim, BK; Kim, BO; Kim, JS; Ko, YG; Kwon, HM; Lee, BH; Lee, BK; Lee, SH; Min, PK; Oh, SJ; Ryu, SK; Yang, JY; Yoon, JH; Yoon, YW | 1 |
Akcay, B; Camsari, A; Doven, O; Erol, T; Kocum, T; Ozcan, T; Yurtdas, M | 1 |
Kojuri, J; Mirabadi, M; Mollazadeh, R; Ostovan, MA | 1 |
Byrne, RA; Kastrati, A | 1 |
De Caterina, R; Zimarino, M | 1 |
Böhm, M; Cremers, B; Kaufels, N; Kühler, M; Mahnkopf, D; Scheller, B; Speck, U | 1 |
Basoglu, A; Benit, E; De Wolf, A; Vranckx, P | 1 |
Botker, HE; Christiansen, EH; Galloe, AM; Hansen, KN; Helqvist, S; Jensen, LO; Lassen, JF; Maeng, M; Thayssen, P; Thuesen, L | 1 |
Billinger, M; Flueckiger, A; Hess, OM; Meier, P; Mettler, D; Schaffner, T; Strahm, Y; Studer, U | 1 |
Blanchard, D; Brunel, P; Carrié, D; Eltchaninoff, H; Fajadet, J; Gilard, M; Glatt, B; Le Breton, H; Lefèvre, T; Levy, G; Maupas, E; Silvestri, M | 1 |
Fajadet, J; Farah, B; Martin, G; Oreglia, JA; Pavei, A; Sauguet, A; Sharif, F; Tousek, P | 1 |
Bonello, L; De Labriolle, A; Lemesle, G; Pakala, R; Scheinowitz, M; Waksman, R | 1 |
Baim, DS; Deshpande, MC; Kandzari, DE; Malik, AZ; Maloney, TH; Mayor, M; Minor, RJ; O'Neill, W; Strauss, WE | 1 |
Darremont, O; de Marco, F; Garot, P; Lefèvre, T; Leymarie, JL; Louvard, Y; Morice, MC; Routledge, H; Silvestri, M; Unterseeh, T; Vaquerizo, B; Zwahlen, M | 1 |
Choi, CU; Kim, EJ; Kim, JW; Na, JO; Oh, DJ; Park, CG; Rha, SW; Seo, HS; Suh, SY | 1 |
Brodie, BR; Dangas, G; Dudek, D; Gersh, BJ; Guagliumi, G; Kellock, A; Lansky, AJ; Mehran, R; Möckel, M; Ochala, A; Parise, H; Peruga, JZ; Pocock, SJ; Stone, GW; Witzenbichler, B; Wong, SC | 1 |
Baim, DS; Cannon, LA; Dobies, D; Hall, JJ; Lim, ST; Lucca, MJ; Mahmud, E; Mandinov, L; Mann, T; McClean, D; Ormiston, JA; Popma, JJ; Turco, MA; Weissman, N | 1 |
Holmes, DR; Patel, M | 1 |
Chevalier, B; Cutlip, DE; Di Mario, C; Fitzgerald, PJ; Grube, E; Neumann, FJ; Ormiston, J; Popma, JJ; Ribichini, F; Schwartz, LB; Urban, P; Whitbourn, R; Williams, DO | 1 |
Bocksch, W; Boxberger, M; Degenhardt, R; Gross, M; Horstkotte, D; Nienaber, C; Schneider, H; Unverdorben, M; Vallbracht, C; Wiemer, M | 1 |
Breall, JA; Cox, DA; Dawkins, KD; Hood, KL; Horwitz, PA; Lasala, JM; Mahoney, PD; Mandinov, L; Morris, DL; Shaw, D | 1 |
Inami, S; Mizuno, K; Murakami, D; Ohba, T; Seino, Y; Takano, M; Yamamoto, M | 1 |
Arruda, JA; Barbosa, MR; Brito, FS; Caramori, PR; Lemos, PA; Lima, AA; Lima, VC; Martinez, EE; Medeiros, CR; Moulin, B; Oliveira, LA; Perin, MA; Ribeiro, EE | 1 |
Hong, MK; Kim, YH; Lee, CW; Lee, JY; Lee, SW; Park, DW; Park, SJ; Park, SW; Yun, SC | 1 |
Vlaar, PJ; Zijlstra, F | 1 |
Berger, P; Cohen, DJ; Cutlip, D; Goldberg, S; Hong, M; Kellett, M; Kleiman, N; Mauri, L; Novack, V; Pencina, M; Raizner, AE; Waksman, R; Yen, CH | 1 |
Changqi, J; Changsheng, M; Chengxiong, G; Fang, C; Fangjiong, H; Jiahui, W; Jianzeng, D; Junping, K; Qiang, L; Rong, H; Shaoping, N; Shuzheng, L; Xiaohui, L; Xin, D; Xinmin, L; Xuesi, W; Yan, Q; Yin, Z; Yujie, Z | 1 |
Akaike, M; Iwase, T; Koshiba, K; Kusunose, K; Niki, T; Sata, M; Soeki, T; Taketani, Y; Tomita, N; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K | 1 |
Krylov, AL | 1 |
Bae, JH; Cha, TJ; Choi, JW; Chung, WY; Hur, SH; Hwang, HK; Hyon, MS; Jeon, HK; Kim, BO; Kim, DI; Kim, HS; Kim, SJ; Kim, SW; Lee, SG; Moon, KW; Park, JS; Park, KS; Park, KW; Seo, JB; Youn, TJ | 1 |
Fitzgerald, P; Kandzari, DE; Kirtane, AJ; Leon, MB; Mauri, L; McLaurin, B; O'Shaughnessy, C; Overlie, P; Patel, R; Popma, JJ; Solomon, S | 1 |
Applegate, RJ; Cao, S; Doostzadeh, J; Gordon, PC; Hermiller, JB; Lansky, AJ; Stone, GW; Sudhir, K; Weinsier, SB | 1 |
Jang, EH; Miller, KM; Saltzman, WM; Sirianni, RW | 1 |
Chen, J; Gao, R; Gao, Z; Li, J; Qiao, S; Qin, X; Wu, Y; Xu, B; Yang, Y; Yuan, J | 1 |
Carrie, D; Chevalier, B; Detiege, D; Garcia, E; Hauptmann, KE; Koolen, J; Morice, MC; Nagai, H; Park, SJ; Paunovic, D; Schuler, G; Serruys, PW; Silber, S; Suryapranata, H; van Es, GA; Wijns, W | 1 |
Dippon, J; Gawaz, M; Geisler, T; Göhring-Frischholz, K; Haase, KK; Hartmann, U; Herdeg, C; May, AE; Nusser, T; Wöhrle, J; Zürn, C | 1 |
Ackermann, H; Boxberger, M; Buerke, M; Cremers, B; Degenhardt, R; Figulla, HR; Hardt, S; Heuer, H; Kleber, FX; Leschke, M; Scheller, B; Unverdorben, M; Vallbracht, C | 1 |
Dong, L; Ge, J; Zhang, F | 1 |
Ehara, M; Habara, M; Katoh, O; Kinoshita, Y; Matsubara, T; Nasu, K; Suzuki, T | 1 |
Colombo, A; Latib, A | 1 |
Hermiller, J; Lansky, A; Miquel-Hebert, K; Onuma, Y; Serruys, PW; Seth, A; Sood, P; Stone, GW; Sudhir, K; Veldhof, S; Yu, S | 1 |
Bocksch, W; Boxberger, M; Degenhardt, R; Horstkotte, D; Nienaber, C; Schneider, H; Unverdorben, M; Vallbracht, C; Wiemer, M | 1 |
Kandzari, DE; Lee, MS; Liao, H; Mahmud, E; Tobis, JM; Yang, T | 1 |
Bhatia, R; Ehdaie, A; Favaretto, E; Lee, MS; Tarantini, G; Tobis, J; Xhaxho, J; Yang, T | 1 |
Han, KH; Kang, SJ; Kim, JJ; Kim, YH; Lee, CW; Lee, SW; Mintz, GS; Park, DW; Park, SJ; Park, SW | 1 |
Bezerra, HG; Biondi-Zoccai, G; Costa, MA; Fiocca, L; Guagliumi, G; Lortkipanidze, N; Matiashvili, A; Musumeci, G; Sirbu, V; Suzuki, N; Trivisonno, A; Valsecchi, O | 1 |
AbuSamra, M; Buszman, P; Kałuza, G; Liszka, Ł; Milewski, K; Musioł, E; Pajak, J; Trznadel, S; Zurakowski, A | 1 |
Ball, MW; Bertolet, B; Cannon, LA; Dauber, IM; Dawkins, KD; Feldman, RL; Foster, MC; Kabour, A; Kereiakes, DJ; Magorien, R; Popma, JJ; Rabinowitz, AC; Underwood, P; Wang, JC; Whitbourn, R | 1 |
Bhambhani, A; Billinger, M; Cook, S; Hellige, G; Hofmann, A; Jüni, P; Meier, B; Millauer, N; Räber, L; Seiler, C; Togni, M; Urwyler, N; Vogel, R; Wandel, S; Wenaweser, P; Windecker, S | 1 |
Chong, E; Hou, XM; Liang, S; Poh, KK; Tan, HC | 1 |
Chae, IH; Cho, YS; Choi, DH; Choi, DJ; Chung, WY; Kang, HJ; Kang, SH; Kim, HS; Koo, BK; Lee, HY; Oh, BH; Park, KH; Park, KW; Park, YB; Yeon, TJ | 1 |
Cheng, JM; Eindhoven, J; Garcia-Garcia, HM; Garg, S; Girasis, C; Kukreja, N; Onuma, Y; Piazza, N; Serruys, PW; Valgimigli, M; van Domburg, R | 1 |
Kang, SJ; Kim, WJ; Kim, YH; Lee, CW; Lee, JY; Lee, SW; Park, DW; Park, SJ; Park, SW; Yun, SC | 1 |
Chen, JP; Chen, SL; Jiang, Q; Kan, J; Mintz, G; Stone, GW; Sun, X; Xu, B; Xu, Y; Ye, F; Zhang, A; Zhang, J | 1 |
Banning, AP; Lim, CC | 1 |
Bandinelli, L; Coppolaro, A; Cortese, B; Limbruno, U; Micheli, A; Picchi, A; Severi, S | 1 |
Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Otake, H; Sakurai, R; Shimohama, T; Sood, P; Stone, GW; Sudhir, K; Tsujino, I; Waseda, K; Yamasaki, M | 1 |
Bae, JH; Cha, KS; Chae, SC; Gwon, HC; Hong, SJ; Hur, SH; Kim, MH; Lim, DS; Park, HS | 2 |
Birkmeier, KA; Byrne, RA; Holle, H; Kastrati, A; Kufner, S; Laugwitz, KL; Massberg, S; Mehilli, J; Schömig, A; Schulz, S; Tiroch, K | 1 |
Antoniucci, D; Bernardi, V; Bettinoti, M; Curotto, V; Delacasa, A; Fernandez-Pereira, C; Mieres, J; Palacios, IF; Rodriguez, AE; Rodriguez-Granillo, AM; Rodriguez-Granillo, G; Rubilar, B; Santaera, O; Tronge, J; Vigo, CF | 1 |
Chen, SL; Chen, YD; Fang, WY; Hu, DY; Kan, J; Kwan, TW; Lin, S; Liu, ZZ; Qian, J; Shan, SJ; Sun, XW; Tian, NL; Wei, M; Yang, S; Ye, F; Yuan, ZB; Zhang, JJ; Zhu, ZS | 1 |
Hong, GR; Hur, SH; Kim, DI; Kim, DS; Kim, HT; Kim, KB; Kim, U; Kim, YJ; Lee, SH; Nam, CW; Park, JS; Yang, TH | 1 |
Cutlip, DE; Kandzari, DE; Leon, MB; Liberman, H; Mauri, L; Moses, J; Nikolsky, E; Patterson, J; Wilson, H | 1 |
Hillegass, WB | 1 |
Park, SJ | 1 |
Chae, IH; Cho, YS; Choi, DJ; Chung, WY; Kang, HJ; Kim, HS; Koo, BK; Lee, HY; Oh, BH; Park, JJ; Park, KW; Park, YB; Seo, JB; Yang, HM; Yeon, TJ | 1 |
Finn, AV; Kolodgie, FD; Ladich, ER; Nakazawa, G; Virmani, R; Vorpahl, M | 1 |
Ahn, T; Han, SH; Kang, WC; Lee, K; Moon, CI; Park, YM; Shin, EK; Shin, KC; Shin, MS | 1 |
Kang, SJ; Kim, PJ; Kim, WJ; Kim, YH; Lee, CW; Lee, JY; Lee, SH; Park, DW; Park, HJ; Park, SJ; Park, SW; Seung, KB | 1 |
Bayer, G; Byrne, RA; Joner, M; Lapointe, JM; Radke, PW; Steigerwald, K; Wittchow, E | 1 |
Butman, SM | 1 |
Chae, JK; Cho, YH; Choi, SW; Chun, KJ; Jeong, JO; Kang, SJ; Kim, HS; Kim, JH; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Rhee, KS; Seong, IW; Yun, SC | 1 |
Freitas, FR; Lourenço-Filho, DD; Maranhão, RC; Méndez-Contreras, CA; Stolf, NA; Tavares, ER | 1 |
Baars, T; Böse, D; Degen, H; Eggebrecht, H; Erbel, R; Haude, M; Heusch, G; Kleinbongard, P; Konorza, T; Levkau, B; Möhlenkamp, S; Steinhilber, F | 1 |
Dänschel, W; Desch, S; Erbs, S; Gielen, S; Kleinertz, K; Lauer, B; Linke, A; Möbius-Winkler, S; Schloma, D; Schuler, G; Thiele, H; Yu, J | 1 |
Antoniucci, D; Buonamici, P; Carrabba, N; Cerisano, G; Migliorini, A; Parodi, G; Valenti, R; Vergara, R | 1 |
Behrens, S; Chevalier, B; Gutiérrez-Chico, JL; Harald, D; Hoffmann, S; Nienaber, C; Serruys, PW; Silber, S; Slagboom, T; Suryapranata, H; Wiemer, M; Witzenbichler, B | 1 |
Almasood, AS; Džavík, V; Freixa, X; Khan, SQ; Mackie, K; Osherov, A; Seidelin, PH; Wainstein, R | 1 |
Birkemeyer, R; Markovic, S; Miljak, T; Nguyen, TV; Rittger, H; Rottbauer, W; Sinha, A; Spiess, J; Wöhrle, J | 1 |
Cannon, LA; Coe, J; Cutlip, DE; Fitzgerald, PJ; Gray, WA; Henry, TD; Hermiller, JB; Heuer, H; Mann, JT; Midei, MG; O'Shaughnessy, CD; Overlie, PA; Popma, JJ; Schwartz, LB; Stuckey, TD; Whitbourn, R; Williams, DO; Yeung, AC | 1 |
Agnifili, M; Bedogni, F; Brambilla, N; Lanotte, S; Latini, RA; Laudisa, ML; Pizzocri, S; Testa, L | 1 |
Gurbel, PA; Kubica, J; Navarese, EP | 1 |
Garcia-Garcia, HM; Garg, S; Girasis, C; Lüscher, TF; Morel, MA; Räber, L; Sarno, G; Serruys, PW; Windecker, S | 1 |
Ciçek, D; Kalay, N; Müderrisoğlu, H; Pekdemir, H | 1 |
Scheller, B; Schnorr, B; Speck, U | 1 |
Blanchard, D; Brunel, P; Carrié, D; Darremont, O; Dibie, A; Eltchaninoff, H; Fajadet, J; Gilard, M; Koning, R; Lablanche, JM; Lefèvre, T; Moynagh, A; Silvestri, M | 1 |
Herdeg, C | 1 |
Ackermann, H; Ahmad, WA; Ali, RM; bin Elis, S; bin Ismail, O; Boxberger, M; Degenhardt, R; Kamar, Hb; Kui-Hian, S; Ong, TK; Tresukosol, D; Udychalerm, W; Unverdorben, M; Zambahari, R | 1 |
Kang, SH; Kim, HS; Park, KW | 1 |
Claessen, BE; Cristea, E; Fahy, M; Kedhi, E; Kereiakes, DJ; Lansky, AJ; Parise, H; Serruys, PW; Simonton, CA; Smits, PC; Sood, P; Stone, GW; Sudhir, K | 1 |
Fukuda, Y; Hashimoto, M; Iwamoto, A; Iwamoto, Y; Iwasaki, T; Kihara, Y; Kinoshita, H; Okamoto, M | 1 |
Dobrzycki, S; Formuszewicz, R; Gil, RJ; Kardaszewicz, P; Kern, A; Lekston, A; Lesiak, M; Michałek, A; Vassiliev, D; Wójcik, J | 1 |
Kochman, W | 1 |
Bezerra, HG; Biondi-Zoccai, G; Capodanno, D; Costa, MA; Fiocca, L; Guagliumi, G; Ikejima, H; Lortkipanidze, N; Matiashvili, A; Musumeci, G; Sirbu, V; Tahara, S; Valsecchi, O; Vassileva, A; Wang, W | 1 |
Byrne, RA; Kastrati, A; King, L; Mehilli, J; Pache, J; Schömig, A | 1 |
Biondi-Zoccai, G; Briguori, C; D'Ascenzo, F; De Waha, A; Della Riva, D; Kaiser, C; Kedhi, E; Kim, HS; Kimura, T; Kirtane, AJ; Leon, MB; Marullo, A; Palmerini, T; Sabatè, M; Sangiorgi, D; Sardella, G; Smits, PC; Stettler, C; Stone, GW | 1 |
Capodanno, D; Facchin, M; Lettieri, C; Mancone, M; Meliga, E; Menozzi, A; Musumeci, G; Saia, F; Tamburino, C; Tarantini, G | 1 |
Almasood, AS; Džavík, V; Freixa, X; Horlick, EM; Ing, D; Khan, SQ; Mackie, K; Osten, M; Overgaard, CB; Seidelin, PH | 1 |
Bode, Ch; Brachmann, J; Brunner, M; Gutleben, KJ; Heitzer, T; Hoffmann, R; Horstkotte, D; Kollum, M; Meinertz, T; Schmoor, C; Schultheiss, HP; Wiemer, M; Witzenbichler, B; Zehender, M | 1 |
Billinger, M; Eberli, F; Hitz, S; Jüni, P; Kalesan, B; Meier, B; Pfäffli, N; Pilgrim, T; Pulver, C; Räber, L; Stefanini, GG; Stettler, C; Windecker, S; Zanchin, T | 1 |
Gruberg, L; Parikh, PB | 1 |
Homma, S; Ichikawa, A; Isobe, K; Kikuchi, N; Sakamoto, S; Sano, G; Satoh, K; Shibuya, K; Sugino, K; Takai, Y | 1 |
Darremont, O; Garot, P; Lefèvre, T; Leymarie, JL; Louvard, Y; Meftout, B; Morice, MC; Moynagh, A; Mylotte, D; Silvestri, M; Vaquerizo, B | 1 |
Buszman, PE; Buszman, PP; Drzewiecki, J; Granada, JF; Kaluza, GL; Kozlowski, M; Milewski, K; Orlik, B; Peppas, A; Pruski, M; Trela, B | 1 |
Beeler, R; Cuculi, F; Erne, P; Young, M | 1 |
Ahn, JM; Kang, SJ; Kim, WJ; Kim, YH; Lee, BK; Lee, CW; Lee, JH; Lee, JY; Lee, SW; Park, DW; Park, SJ; Park, SW; Seong, IW; Song, HG; Yun, SC | 1 |
Hariki, H; Hayashi, T; Hiranuma, N; Hirata, K; Inoue, T; Iwasaki, M; Kadotani, M; Kato, H; Kawamori, H; Kinutani, H; Konishi, A; Kozuki, A; Matsumoto, D; Miyoshi, N; Nagoshi, R; Nakagawa, M; Nishio, R; Ohnishi, Y; Ohsue, T; Otake, H; Shinke, T; Shite, J; Takaya, T; Taniguchi, Y; Yamada, S; Yasaka, Y; Yokoyama, M | 1 |
Levenson, B | 1 |
Büllesfeld, L; Gerckens, U; Grube, E; Müller, R | 1 |
Kaulen, H | 1 |
Bergin, P; Caputo, R; Cox, DA; Ellis, SG; Greenberg, J; Hermiller, J; Mann, JT; O'Shaughnessy, C; Popma, JJ; Russell, ME; Stone, GW; Turco, M | 2 |
Bhatia, R; Bhatia, V; Dhindsa, M | 1 |
Valdés Chávarri, M | 1 |
Macaya, C | 1 |
Auer, J; Berent, R; Eber, B; Weber, T | 1 |
Alfonso, F; Angiolillo, DJ; Macaya, C; Sabatá, M | 1 |
Chieffo, A; Colombo, A | 1 |
Buellesfeld, L; Grube, E | 1 |
Belardi, J; Colombo, A; Dawkins, K; Drzewiecki, J; Grube, E; Hamburger, J; Hauptman, K; Koglin, J; Nienaber, C; Pfisterer, M; Rutsch, W; Silber, S; Webb, J; Zmudka, K | 1 |
Aoki, J; McFadden, EP; Ong, AT; Serruys, PW | 1 |
Jung, F; Kappert, U; Knaut, M; Matschke, K; Park, JW; Tugtekin, SM | 1 |
Applegate, RA; Cannon, LA; Costa, RA; Cox, DA; Cristea, E; Farah, A; Kaplan, B; Kereiakes, DJ; Knopf, WD; Lansky, AJ; Leon, MB; Midei, M; Mintz, GS; Mooney, M; O'Neill, WW; O'Shaughnessy, C; Stone, GW; Tannenbaum, MA; Tsuchiya, Y; Wong, SC; Yakubov, S | 1 |
Teirstein, PS | 1 |
Holmes, DR | 1 |
Ajani, AE; Waksman, R | 1 |
Arampatzis, CA; de Feyter, PJ; Hoye, A; Lemos, PA; McFadden, E; Ong, AT; Serruys, PW; Sianos, G; van der Giessen, WJ; van Domburg, RT; van Mieghem, CA | 1 |
Doevendans, PA; Elsman, P; Stella, PR | 1 |
Bartorelli, A; Berardi, F; Bolognese, L; Danzi, GB; Della Grazia, E; Galassi, AR; Indolfi, C; Klugmann, S; Marzilli, M; Montinaro, A; Paloscia, L; Petronio, AS; Scherillo, M; Vassanelli, C | 1 |
Espallargues, M; Oliva, G; Pons, JM | 1 |
Hermiller, JB | 1 |
Hung, JS; Lau, KW; Sigwart, U | 1 |
Marco, J | 1 |
Abramjuk, C; Bernhardt, U; Böhm, M; Nickenig, G; Scheller, B; Speck, U | 1 |
Liakishev, AA | 1 |
Airoldi, F; Di Mario, C; Melikian, N | 1 |
Grover, A; Malhotra, S; Pandhi, P; Shafiq, N; Uboweja, A | 1 |
Kim, JW; Oh, DJ; Park, CG; Seo, HS | 1 |
Dangas, G; Ellis, SG; Fish, D; Katz, S; Martin, S; Mehran, R; Russell, ME; Shlofmitz, R; Stone, GW | 1 |
Chew, DP | 1 |
Agostoni, P; Airoldi, F; Barbagallo, R; Biondi-Zoccai, GG; Briguori, C; Carlino, M; Chieffo, A; Colombo, A; Falchetti, E; Iakovou, I; Margheri, M; Melzi, G; Michev, I; Montorfano, M; Remigi, E; Sangiorgi, GM; Tamburino, C; Tsagalou, E; Vittori, G | 1 |
Buellesfeld, L; Gerckens, U; Grube, E; Hauptmann, KE; Lim, V; Mueller, R; Russell, ME; Silber, S | 1 |
Abizaid, A; Aoki, J; Belardi, J; Bonnier, H; Bressers, M; Condado, J; den Heijer, P; Gambone, L; Litvack, F; McClean, D; Pieper, M; Serruys, PW; Sianos, G; Smits, P; Sousa, E; Symons, J; Verheye, S | 1 |
Airoldi, F; Carlino, M; Chieffo, A; Colombo, A; Corvaja, N; Cosgrave, J; Ge, L; Iakovou, I; Michev, I; Montorfano, M; Sangiorgi, GM | 1 |
Buellesfeld, L; Gerckens, U; Grube, E; Mueller, R; Schmidt, T | 1 |
Jang, Y; Jeon, DW; Kim, BO; Ko, YG; Kwon, HM; Lee, SH; Park, SH; Ryu, SK; Yang, JY; Yoon, JH | 1 |
Kipshidze, NN; Leon, MB; Moses, JW; Stone, GW; Tsapenko, MV | 1 |
Hoye, A; McFadden, EP; Ruiz-Cantador, J | 1 |
Curzen, N; Hatrick, R; Teece, S | 1 |
Collins, M; Ellis, SG; Jones, M; Kereiakes, DJ; Leon, MB; McMartin, D; Mehran, R; Moussa, I; Popma, JJ; Russell, ME; Rutherford, B; Stone, GW | 1 |
Allen, F; Atherton, JJ; Burgess, DC; Howard, K; King, R; Lord, SJ; Marinovich, L | 1 |
Agostoni, P; Airoldi, F; Biondi-Zoccai, GG; Bonizzoni, E; Carlino, M; Chieffo, A; Colombo, A; Corvaja, N; Cosgrave, J; Ge, L; Iakovou, I; Michev, I; Montorfano, M; Sangiorgi, GM | 1 |
Gil, RJ | 1 |
Bee, H; Lee, CH; Lim, YT; Low, A; Soon, CY; Tan, HC; Teo, SG; Zhang, JJ | 1 |
Boccara, F; Cohen, A; Teiger, E | 1 |
Antoniucci, D; Carrabba, N; Migliorini, A; Moschi, G; Parodi, G; Vergara, R | 1 |
Abbate, A; Agostoni, P; Biondi-Zoccai, GG; Cosgrave, J; Pilati, M; Valgimigli, M | 1 |
Ahn, TH; Han, SH; Kang, WC; Shin, EK | 1 |
Cheong, SS; Choi, BR; Hong, MK; Kim, JJ; Kim, MJ; Kim, YH; Lee, BK; Lee, CW; Park, DW; Park, KH; Park, KM; Park, SJ; Park, SW | 1 |
Bhargava, B; Karthikeyan, G; Mishra, S; Raju, R; Reddy, NK; Singh, S; Somaraju, B; Virmani, R; Waksman, R | 1 |
Arbit, B; Curran, PJ; Currier, JW; Kobashigawa, JA; Li, H; Takano, Y; Tanaka, K; Tobis, JM; Yeatman, LA | 1 |
Hoye, A; Serruys, PW; Sianos, G; Vaina, S | 1 |
Ahn, TH; Han, SH; Kang, WC; Oh, KJ; Shin, EK | 1 |
Block, PC; Cates, CU; Douglas, JS; Ghazzal, Z; Morris, DC; Rab, ST; Vassiliades, TA | 1 |
Airoldi, F; Aoki, J; Carlino, M; Chieffo, A; Colombo, A; Corvaja, N; Cosgrave, J; de Feyter, PJ; Ge, L; Hoye, A; Iakovou, I; Michev, I; Montorfano, M; Ong, AT; Rodriguez Granillo, GA; Sangiorgi, GM; Serruys, PW; Sianos, G; Valgimigli, M; van der Giessen, WJ; van Domburg, RT; van Mieghem, CA | 1 |
Grover, A; Malhotra, S; Pandhi, P; Shafiq, N; Sidhu, S | 1 |
Ausiello, A; Contegiacomo, G; De Caterina, R; Di Iorio, C; Renda, G; Riccardi, I; Zimarino, M | 1 |
Agostoni, P; Antoniucci, D; Biondi-Zoccai, GG; Colombo, A; Cosgrave, J; Di Mario, C; Grube, E; Reimers, B; Sangiorgi, GM; Tamburino, C | 1 |
Kim, JW; Oh, DJ; Park, CG; Rha, SW; Seo, HS; Suh, SY | 1 |
Chronos, N; Conway, D; Jabara, R; King, S; Mabin, T; Molema, W; Park, K; Robinson, K; Tondato, F | 1 |
Alfonso, F; Angiolillo, DJ; Bass, TA; Cervinka, P; Corros, C; Costa, MA; Futamatsu, H; Hernandez-Antolin, R; Jiang, J; Jimenez-Quevedo, P; Macaya, C; Morikawa-Futamatsu, K; Sabaté, M | 1 |
Hong, MK; Kim, JJ; Kim, YH; Lee, CW; Park, KH; Park, SJ; Park, SW | 1 |
Khabbaz, KR; Lerner, AB; Mahmood, F; Subramaniam, B | 1 |
Aurier, E; Benassi, A; Geraci, G; Grilli, R; Guastaroba, P; Manari, A; Marzocchi, A; Piovaccari, G; Saia, F; Sangiorgio, P; Santarelli, A; Tarantino, F; Vecchi, G | 1 |
Blindt, R; Hoffmann, R; Iofina, E; Kelm, M; Kühl, H; Langenberg, R | 1 |
Adesanya, AO; Banerjee, S; Brilakis, ES; Compton, PA; Zankar, AA | 1 |
De Feyter, P; de Jaegere, P; Garcia-Garcia, HM; Malagutti, P; Rodriguez Granillo, GA; Serruys, PW; Tsuchida, K; Valgimigli, M; Van der Giessen, WJ; Van Domburg, RT; van Mieghem, CA | 1 |
Mitka, M | 1 |
Carrozza, JP; Jeremias, A; Wernick, MH | 1 |
Daemen, J; de Jaegere, P; García-García, HM; Serruys, PW; Tanimoto, S; Tsuchida, K; van Domburg, RT | 1 |
Bader, F; Brunner-La Rocca, HP; Buser, PT; Hunziker, P; Jeger, R; Kaiser, C; Mueller, C; Osswald, S; Pfisterer, M; Rickenbacher, P | 1 |
Albaladejo, P; Lehot, JJ; Marcotte, G; Marret, E; Monier, F; Piriou, V; Samama, CM; Vichova, Z | 1 |
Airoldi, F; Antoniucci, D; Barbagallo, R; Colombo, A; Di Mario, C; Godino, C; Goktekin, O; Grube, E; Morici, N; Sangiorgi, GM; Tamburino, C; Zoccai, GB | 1 |
Gollapudi, RR; Lee, SS; Price, MJ; Teirstein, PS; Valencia, R; Wong, GB | 1 |
Flensted Lassen, J; Maeng, M; Okkels Jensen, L; Rasmussen, K; Romer Krusell, L; Thayssen, P; Thuesen, L | 1 |
Baz, JA; Bordes, P; de la Torre, JM; Hernandez, JM; Iñiguez, A; Lozano, I; Mainar, V; Mauri, J; Sanmartin, M | 1 |
Arnold, ND; Bowles, J; Gunn, J; Heppenstall, J; Korgul, P; Morton, AC; Siotia, A | 1 |
Meier, B; Meier, P; Seiler, C; Togni, M; Wenaweser, P; Windecker, S; Zbinden, R | 1 |
Lang, NN; Newby, DE | 1 |
Cocchia, R; Cook, S; Hess, OM; Meier, B; Räber, L; Togni, M; Wenaweser, P; Windecker, S | 1 |
Kaplan, AV | 1 |
Barsotti, A; Branchitta, G; Ciabatti, N; Cortese, B; De Carlo, M; Gherarducci, G; Gistri, R; Papini, B; Petronio, AS | 1 |
Ahn, TH; Choi, IS; Chung, WJ; Han, SH; Kang, WC; Koh, KK; Oh, KJ; Shin, EK; Shin, MS | 2 |
Han, KH; Hong, MK; Kang, DH; Kim, JJ; Kim, YH; Lee, CW; Park, CB; Park, DW; Park, SJ; Park, SW; Song, JK | 1 |
Chae, IH; Cho, HJ; Cho, YS; Choi, DJ; Chung, WY; Kang, HJ; Kim, HS; Kim, MS; Koo, BK; Oh, BH; Park, JS; Park, YB; Sohn, DW; Suh, JW; Youn, TJ | 1 |
Colombo, A | 1 |
Agostoni, P; Airoldi, F; Biondi-Zoccai, GG; Carlino, M; Chieffo, A; Colombo, A; Corbett, S; Cosgrave, J; Ge, L; Melzi, G; Michev, I; Montorfano, M; Sangiorgi, GM | 1 |
Calvo Cebollero, I; Diarte de Miguel, JA; Galache Osuna, JG; Lukic, A; Placer Peralta, LJ; Sánchez-Rubio Lezcano, J | 1 |
Yamaguchi, T | 1 |
Colombo, A; Dawkins, KD; Ellis, SG; Grube, E; Koglin, J; Popma, J; Stone, GW | 1 |
Hong, MK; Kim, JJ; Kim, YH; Lee, CW; Lee, SW; Park, DW; Park, SJ; Park, SW | 1 |
Al Suwaidi, J; El-Menyar, AA; Holmes, DR | 1 |
Alfonso, F; Bañuelos, C; Costa, J; Escaned, J; Guardado, JH; Hernández, R; Macaya, C; Moreno, R; Perez-Viscayno, MJ; Segura, L | 1 |
Bush, CA; Doshi, AA; Magorien, RD; Mazzaferri, EL; Orsini, AR; Schmidt, WT | 1 |
Gunalingam, B; Wang, D | 1 |
Baim, DS; Cannon, LA; Chan, C; Hall, JJ; Koglin, J; Mandinov, L; Mann, T; McGarry, TF; Mishkel, GJ; O'Shaughnessy, CD; Ormiston, JA; Popma, JJ; Turco, MA; Webster, MW; Wu, CJ | 1 |
Finn, AV; Gold, HK; Joner, M; Kolodgie, FD; Mont, EK; Nakazawa, G; Virmani, R | 1 |
Agostoni, P; Clementi, F; Cola, C; Colombo, A; Melzi, G; Romitelli, P; Sangiorgi, G; Virmani, R | 1 |
Aurier, E; Benassi, A; Cremonesi, A; Grilli, R; Guastaroba, P; Magnavacchi, P; Manari, A; Maresta, A; Marzocchi, A; Percoco, G; Piovaccari, G; Saia, F; Varani, E | 1 |
Boey, F; Venkatraman, S | 1 |
Aliaga, Jdel C; de Abreu, LM; Forte, AA; Hayashi, J; Meireles, GC; Sumita, MK | 1 |
Bennett, MR | 1 |
Barlis, P; Di Mario, C; Dimopoulos, K; Galassi, A; Goktekin, O; Kaplan, S; La Manna, A; Tanigawa, J | 1 |
Abizaid, A; Cano, M; Centemero, M; Chaves, A; Costa, R; de Ribamar Costa, J; Feres, F; Maldonado, G; Mattos, LA; Moreira, AC; Quizhpe, AR; Sousa, AM; Sousa, JE; Staico, R; Tanajura, LF | 1 |
Bourantas, CV; Fotiadis, DI; Katsouras, CS; Michalis, LK; Papafaklis, MI; Theodorakis, PE | 1 |
Harish, CR; Satish, B; Tressa, K | 1 |
Celik, T; Dogru, MT; Isik, E; Iyisoy, A | 1 |
Erglis, A; Jegere, S; Kumsars, I; Mintale, I; Narbute, I; Saltups, A; Strazdins, U; Zakke, I | 1 |
Leon, MB; Moses, JW; Stone, GW | 1 |
Coolong, A; Kuntz, RE | 1 |
Billinger, M; Cook, S; Corti, R; Eber, S; Eberli, FR; Garachemani, A; Hess, OM; Jüni, P; Lüscher, TF; Maier, W; Meier, B; Roffi, M; Seiler, C; Togni, M; Vogel, R; Wandel, S; Wenaweser, P; Widmer, J; Windecker, S | 1 |
Clark, LT; Hannan, EL; Holmes, DR; King, SB; Racz, M; Sharma, S; Walford, G | 1 |
Gunalingam, B; Henderson, D | 1 |
de Korte, FI; Ten Berg, JM; van Werkum, JW; Vijverberg, PL | 1 |
Baek, SH; Chang, K; Chung, WS; Jeon, DS; Kim, DB; Kim, MJ; Kim, PJ; Lee, MY; Lim, SM; Seung, KB; Shin, DI | 1 |
Conrad, A; Hartmann, F; Jain, D; Kurowski, V; Radke, PW; Remmel, M; Schunkert, H; Thomsen, C | 1 |
Aranzulla, TC; Colombo, A; Cosgrave, J; Latib, A; Qasim, A | 1 |
Buszman, P; Gil, R; Jaklik, A; Janczak, J; Kałuza, GL; Kiesz, S; Kinasz, L; Kondys, M; Kośmider, M; Król, M; Milewski, K; Przewłocki, T; Rzeszutko, Ł; Rzeźniczak, J; Trznadel, S; Wójcik, J; Zurakowski, A | 1 |
Aoki, J; Collins, M; Dangas, GD; Frankin-Bond, T; Kim, YH; Kimura, M; Kirtane, AJ; Kreps, EM; Lansky, AJ; Leon, MB; Mehran, R; Morales, A; Moses, JW; Moussa, I; Stone, GW; Weisz, G | 1 |
Arcoleo, F; Cillari, E; Enia, F; Lo Giudice, A; Lo Mauro, R; Picone, A; Raspanti, G; Schirosa, M | 1 |
Haase, J; Ruef, J; Schwarz, F; Störger, H | 1 |
Kastrati, A | 1 |
Ahn, Y; Hong, SJ; Hong, YJ; Jeong, MH; Kang, JC; Kim, JH; Lim, DS; Lim, SY; Moon, JY | 1 |
Aoki, J; Collins, M; Dangas, GD; Dasgupta, NK; Franklin-Bond, T; Kim, YH; Kimura, M; Kirtane, AJ; Lansky, AJ; Leon, MB; Mehran, R; Moses, JW; Moussa, I; Parise, H; Solinas, E; Stone, GW | 1 |
Allaqaband, S; Bajwa, T; Djelmami-Hani, M; Maddikunta, R; Shaikh, F; Solis, J | 1 |
Carter, AJ | 1 |
Doevendans, PA; Fanggiday, JC; Guyomi, SH; Stella, PR | 1 |
Krylov, AL; Maslov, LN | 1 |
Cottin, Y | 1 |
Carrié, D; Cherradi, R; Elbaz, M; Ouldzein, H; Puel, J; Zouaoui, W | 1 |
Barlis, P; Di Mario, C; Dimopoulos, K; Ferrante, G; Kaplan, S | 1 |
Chronos, N; Hou, D; Jabara, R; Li, J; Pendyala, L; Robinson, K; Shinke, T | 1 |
Reddy, HK; Sturek, M | 1 |
Gharacholou, SM; Krucoff, MW; Nilsson, KR; Sketch, MH | 1 |
39 review(s) available for paclitaxel and Coronary Stenosis
Article | Year |
---|---|
DES the year in review: controversies.
Topics: Biocompatible Materials; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Diabetes Complications; Disease-Free Survival; Drug-Eluting Stents; Humans; Meta-Analysis as Topic; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Postoperative Complications; Sirolimus; Thrombolytic Therapy; Treatment Outcome | 2013 |
Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis.
Topics: Antineoplastic Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention | 2016 |
Paclitaxel-eluting balloon: from bench to bed.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Equipment Design; Humans; Hyperplasia; Paclitaxel; Prosthesis Design; Thrombosis; Treatment Outcome | 2009 |
[Experience in using stents with an antiproliferative coating in treatment of stenoses and occlusions of coronary arteries. Review of the literature].
Topics: Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Neovascularization, Pathologic; Paclitaxel; Prosthesis Design; Sirolimus; Treatment Outcome | 2008 |
Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus.
Topics: Antineoplastic Agents, Phytogenic; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Treatment Outcome | 2010 |
A pooled gender based analysis comparing the XIENCE V(R) everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention.
Topics: Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Incidence; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Saphenous Vein; Sirolimus; Treatment Outcome; United States | 2010 |
Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Multi-Link Vision stent vs. first-generation drug-eluting stents: systematic review and meta-analysis.
Topics: Chromium Alloys; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Risk Factors; Sirolimus; Stents; Thrombosis; Treatment Outcome; Tubulin Modulators | 2011 |
Review of clinical data with Paccocath- coated balloon catheters.
Topics: Arterial Occlusive Diseases; Catheterization; Constriction, Pathologic; Coronary Stenosis; Equipment Design; Humans; Paclitaxel | 2011 |
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Evidence-Based Medicine; Female; Humans; Incidence; Italy; Male; Paclitaxel; Prognosis; Prosthesis Failure; Radiography; Randomized Controlled Trials as Topic; Risk Assessment; Sirolimus; Stents; Survival Analysis; Thrombosis | 2012 |
Forget Mars and venus, men and women are from the same planet after all.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prognosis; Prosthesis Failure; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Sirolimus; Treatment Outcome | 2012 |
Drug-eluting stents: new era and new concerns.
Topics: Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Coronary Restenosis; Coronary Stenosis; Cost-Benefit Analysis; Drug Implants; Humans; Paclitaxel; Stents | 2004 |
[Is systematic use of drug-eluting stents justified? Arguments in favour].
Topics: Arterial Occlusive Diseases; Clinical Trials as Topic; Combined Modality Therapy; Coronary Stenosis; Drug Delivery Systems; Humans; Paclitaxel; Sirolimus; Stents | 2004 |
[Is systematic use of drug-eluting stents justified? Arguments against].
Topics: Clinical Trials as Topic; Combined Modality Therapy; Coronary Restenosis; Coronary Stenosis; Costs and Cost Analysis; Drug Delivery Systems; Humans; Paclitaxel; Registries; Sirolimus; Stents | 2004 |
Polymer-based paclitaxel-eluting coronary stents. Clinical results in de novo lesions.
Topics: Administration, Topical; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Humans; Paclitaxel; Polymers; Randomized Controlled Trials as Topic; Stents; Treatment Outcome | 2004 |
ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?
Topics: Administration, Topical; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Stenosis; Feasibility Studies; Humans; Immunosuppressive Agents; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome | 2004 |
Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Stenosis; Data Interpretation, Statistical; Delayed-Action Preparations; Humans; Outcome Assessment, Health Care; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Retrospective Studies; Stents; Treatment Outcome | 2004 |
Classification and current treatment options of in-stent restenosis. Present status and future perspectives.
Topics: Administration, Topical; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Humans; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Treatment Outcome | 2004 |
[Do drug-eluting stents influence the spectrum of coronary artery bypass surgery?].
Topics: Administration, Topical; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Artery Bypass; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Equipment Failure Analysis; Humans; Microscopy, Electron, Scanning; Paclitaxel; Sirolimus; Stents; Treatment Outcome | 2004 |
[Italian Consensus Conference on drug-eluting stents].
Topics: Clinical Trials as Topic; Coronary Stenosis; Drug Carriers; Humans; Paclitaxel; Sirolimus; Stents | 2004 |
[Antiproliferative drug-eluting stents: systematic review of the benefits and estimate of economic impact].
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Cost-Benefit Analysis; Drug Delivery Systems; Drug Implants; Humans; Paclitaxel; Sirolimus; Spain; Stents | 2004 |
The current status of stent placement in small coronary arteries < 3.0 mm in diameter.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug Delivery Systems; Equipment Design; Humans; Paclitaxel; Sirolimus; Stents | 2004 |
Coronary bifurcation stenting. Current techniques, outcome and possible future developments.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Stenosis; Drug Therapy, Combination; Equipment Design; Humans; Immunosuppressive Agents; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome | 2004 |
A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease.
Topics: Cell Proliferation; Coronary Restenosis; Coronary Stenosis; Death, Sudden, Cardiac; Drug Implants; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome; Tunica Intima | 2005 |
Update on drug-eluting coronary stents.
Topics: Clinical Trials as Topic; Combined Modality Therapy; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Fibrinolytic Agents; Humans; Paclitaxel; Prosthesis Design; Sirolimus; Stents | 2005 |
A systematic review and economic analysis of drug-eluting coronary stents available in Australia.
Topics: Australia; Coronary Restenosis; Coronary Stenosis; Cost-Benefit Analysis; Equipment Design; Humans; Immunosuppressive Agents; Metals; Paclitaxel; Patient Selection; Polymers; Risk; Sirolimus; Stents; Treatment Outcome | 2005 |
A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.
Topics: Coronary Stenosis; Humans; Immunosuppressive Agents; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2006 |
Drug-eluting stents and stent thrombosis: a cause for concern?
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Stenosis; Coronary Thrombosis; Humans; Immunosuppressive Agents; Incidence; Paclitaxel; Prognosis; Prosthesis Failure; Sirolimus; Stents; Survival Rate | 2006 |
[Percutaneous coronary intervention for the elderly patients].
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Stenosis; Humans; Paclitaxel; Quality of Life; Risk; Sirolimus; Stents | 2007 |
Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years.
Topics: Adolescent; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis; Cardiac Catheterization; Confidence Intervals; Coronary Angiography; Coronary Stenosis; Drug Administration Routes; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Probability; Prosthesis Design; Prosthesis Failure; Randomized Controlled Trials as Topic; Risk Assessment; Stents; Survival Analysis; Taxus; Thrombosis; Time Factors | 2007 |
Left main coronary artery stenosis: state-of-the-art.
Topics: Aged; Biomarkers; C-Reactive Protein; Catheter Ablation; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Echocardiography, Transesophageal; Exercise Test; Female; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Thallium Radioisotopes; Tomography, X-Ray Computed; Treatment Outcome; Tubulin Modulators | 2007 |
Vascular responses to drug eluting stents: importance of delayed healing.
Topics: Aged; Angioplasty, Balloon, Coronary; Animals; Biopsy, Needle; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease Models, Animal; Endothelium, Vascular; Humans; Immunohistochemistry; Middle Aged; Paclitaxel; Prognosis; Prosthesis Design; Rabbits; Risk Factors; Sensitivity and Specificity; Sirolimus; Stents; Time Factors; Wound Healing | 2007 |
Engineering aspects of stents design and their translation into clinical practice.
Topics: Absorbable Implants; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Stenosis; Drug Implants; Equipment Design; Humans; Multicenter Studies as Topic; Paclitaxel; Sirolimus; Stents; Treatment Outcome | 2007 |
Release profiles in drug-eluting stents: issues and uncertainties.
Topics: Animals; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Follow-Up Studies; Humans; Immunosuppressive Agents; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Sirolimus; Stents; Time Factors; Uncertainty | 2007 |
Understanding the drug-eluting stent trials.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Treatment Outcome; Tubulin Modulators | 2007 |
[Paclitaxel-eluting stents in treatment of stenoses and chronic occlusions of coronary arteries].
Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Chronic Disease; Coated Materials, Biocompatible; Coronary Stenosis; Humans; Paclitaxel; Stents; Treatment Outcome | 2007 |
Drug-eluting stents: present and future.
Topics: Animals; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Humans; Molecular Structure; Paclitaxel; Prosthesis Design; Sirolimus; Stents | 2008 |
82 trial(s) available for paclitaxel and Coronary Stenosis
Article | Year |
---|---|
Vascular Response After FP-PES Versus Polymer-Free Paclitaxel-Eluting Stent Implantation in Femoropopliteal Artery Lesions: A Serial Intravascular Ultrasound Study.
Topics: Cardiovascular Agents; Coronary Stenosis; Drug-Eluting Stents; Endovascular Procedures; Femoral Artery; Humans; Japan; Neointima; Paclitaxel; Peripheral Arterial Disease; Polymers; Popliteal Artery; Predictive Value of Tests; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Vascular Patency | 2020 |
Five-year follow-up of the endothelial progenitor cell capturing stent versus the paxlitaxel-eluting stent in de novo coronary lesions with a high risk of coronary restenosis.
Topics: Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Endothelial Progenitor Cells; Humans; Paclitaxel; Percutaneous Coronary Intervention; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Re-Epithelialization; Risk Factors; Time Factors; Treatment Outcome | 2018 |
Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 years.
Topics: Antineoplastic Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome | 2013 |
The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent.
Topics: Aged; Antibodies; Antigens, CD34; Asia; Australia; Brazil; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Endothelial Cells; Europe; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Risk Factors; Sirolimus; Stem Cells; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2013 |
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial.
Topics: Aged; Australia; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Neointima; New Zealand; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2013 |
Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents.
Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Outcome | 2013 |
Randomized trial comparing the efficacy between different types of paclitaxel-eluting stents: the comparison of efficacy between COroflex PLEASe ANd Taxus stent (ECO-PLEASANT) randomized controlled trial.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Sirolimus; Time Factors; Treatment Outcome | 2013 |
Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Circulation; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Endothelium, Vascular; Female; Hemodynamics; Humans; Male; Metals; Microcirculation; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Time Factors; Vasodilator Agents | 2014 |
Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Topics: Aged; Aged, 80 and over; Angina, Stable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome | 2013 |
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2014 |
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-elutin
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Prosthesis Failure; Risk Assessment; Severity of Illness Index; Sirolimus; Spain; Survival Rate; Treatment Outcome | 2014 |
Randomized comparison between polymer-free versus polymer-based paclitaxel-eluting stent: two-year final clinical results.
Topics: Aged; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Prospective Studies; Risk Factors; Single-Blind Method; Treatment Outcome; Ultrasonography, Interventional; Vasculitis, Leukocytoclastic, Cutaneous | 2014 |
A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Treatment Outcome; Tubulin Modulators | 2014 |
Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials.
Topics: Aged; Cohort Studies; Coronary Angiography; Coronary Stenosis; Double-Blind Method; Drug-Eluting Stents; Equipment Failure; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Prospective Studies; Tunica Intima; Ultrasonography, Interventional | 2014 |
Determinants of neointimal proliferation and stent coverage after intracoronary therapy with drug-eluting devices in stable coronary artery disease: role of endothelial progenitor cells and interleukin-1 family cytokines.
Topics: Aged; Cell Count; Cell Proliferation; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Endothelial Progenitor Cells; Everolimus; Female; Humans; Interleukin-1; Male; Middle Aged; Neointima; Paclitaxel; Prognosis; Tomography, Optical Coherence | 2014 |
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study.
Topics: Aged; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease Progression; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Neointima; Paclitaxel; Prosthesis Failure; Sirolimus; Tomography, Optical Coherence; Tubulin Modulators | 2015 |
Stenting and Adjunctive Delivery of Paclitaxel Via Balloon Coating Versus Durable Polymeric Matrix for De Novo Coronary Lesions: Clinical and Angiographic Results from the Prospective Randomized Trial.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Stents | 2015 |
Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Equipment Design; Female; Germany; Humans; Male; Middle Aged; Paclitaxel; Severity of Illness Index; Stents; Time Factors; Treatment Outcome | 2016 |
A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus.
Topics: Aged; Blood Vessel Prosthesis Implantation; Cohort Studies; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Radiography; Sirolimus; Treatment Outcome; Tubulin Modulators | 2008 |
Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Paclitaxel; Prognosis; Prospective Studies; Sirolimus; Systemic Inflammatory Response Syndrome; Treatment Outcome; Tubulin Modulators; Ultrasonography | 2009 |
Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Sirolimus | 2009 |
One-year outcomes from the TAXUS express stent versus cypher stent.
Topics: Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Postoperative Complications; Prosthesis Design; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome; United States | 2009 |
Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Registries; Survival Analysis; Thrombosis; Treatment Outcome | 2009 |
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Recurrence; Retreatment; Risk; Stents; Sweden | 2009 |
Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Feasibility Studies; Female; Humans; Male; Middle Aged; New Zealand; Paclitaxel; Prospective Studies; Prosthesis Design; Severity of Illness Index; Singapore; Thrombosis; Time Factors; Treatment Outcome; United States | 2008 |
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Australia; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Europe; Female; Humans; Logistic Models; Male; Middle Aged; New Zealand; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2008 |
The paclitaxel-eluting Coroflex Please stent study (PECOPS I): the 3-year clinical follow-up.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Risk Assessment; Severity of Illness Index; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program.
Topics: Antineoplastic Agents, Phytogenic; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Paclitaxel; Prospective Studies; Risk Factors; Survival Rate; Time Factors; Treatment Outcome; United States | 2009 |
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Brazil; Cardiovascular Agents; Cardiovascular Diseases; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of p
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Treatment Outcome; Tubulin Modulators | 2009 |
Efficacies of the new paclitaxel-eluting Coroflex Please stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please and Taxus (ECO-PLEASANT) trial: study rationale and design.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Follow-Up Studies; Humans; Paclitaxel; Prospective Studies; Research Design; Sample Size | 2009 |
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetic Angiopathies; Drug-Eluting Stents; Female; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Severity of Illness Index; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; United States | 2009 |
Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: the SPIRIT III 4.0 mm registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prospective Studies; Registries; Risk Assessment; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States | 2010 |
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
Topics: Angioplasty, Balloon, Coronary; Asia; Australia; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Europe; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Risk Assessment; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2009 |
Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Single-Blind Method; Stents; Time Factors; Treatment Outcome; Tunica Intima | 2009 |
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter.
Topics: Aged; Catheterization; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Recurrence; Stents; Treatment Outcome | 2010 |
The paclitaxel-eluting coroflex stent study II (PECOPS II) acute and 6-month clinical and angiographic follow-up, 1-year clinical follow-up.
Topics: Aged; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2010 |
Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Feasibility Studies; Female; Humans; Hyperplasia; Male; Metals; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional | 2010 |
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXU
Topics: Aged; Chromium; Chromium Alloys; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Platinum; Prospective Studies; Single-Blind Method; Treatment Outcome | 2010 |
Eighteen-month clinical safety and efficacy outcomes of sirolimus-, paclitaxel- and zotarolimus-drug eluting stents in diabetic patients undergoing percutaneous coronary intervention for complex coronary artery stenosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Survival Analysis; Treatment Outcome | 2010 |
Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Drug-Eluting Stents; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiography; Treatment Outcome | 2010 |
Comparison of everolimus- versus paclitaxel-eluting stents implanted in patients with diabetes mellitus as evaluated by three-dimensional intravascular ultrasound analysis.
Topics: Aged; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Ultrasonography, Interventional | 2010 |
Comparison of three-year clinical outcomes between sirolimus-versus paclitaxel-eluting stents in diabetic patients: prospective randomized multicenter trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Argentina; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Glycocalyx; Humans; Kaplan-Meier Estimate; Lactic Acid; Logistic Models; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Stents; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States | 2010 |
Comparison of dual drug-eluting Cilotax stent and paclitaxel-eluting Taxus Liberte stent in native coronary artery lesions.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Cilostazol; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Tetrazoles | 2011 |
A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: the LIPSIA Yukon trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Paclitaxel; Polymers; Single-Blind Method; Stents | 2011 |
Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Antigens, CD34; Coated Materials, Biocompatible; Combined Modality Therapy; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Endothelial Cells; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Paclitaxel; Radiography; Single-Blind Method; Stem Cells; Treatment Outcome; Tubulin Modulators | 2011 |
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial.
Topics: Angina Pectoris; Cohort Studies; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Paclitaxel; Prospective Studies; Radiography; Single-Blind Method; Sirolimus; Treatment Outcome | 2012 |
SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularizatio
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Predictive Value of Tests; Prospective Studies; Retrospective Studies; ROC Curve; Severity of Illness Index; Sirolimus; Treatment Outcome; Tubulin Modulators | 2011 |
Clinical outcome of B2/C type isolated proximal LAD disease treated with drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Treatment Outcome | 2011 |
Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chromium Alloys; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Disease-Free Survival; Drug Delivery Systems; Drug-Eluting Stents; Equipment Design; Female; Humans; Kaplan-Meier Estimate; Malaysia; Male; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Stents; Thailand; Time Factors; Treatment Outcome | 2011 |
Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TES
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Polymers; Proportional Hazards Models; Prospective Studies; Prosthesis Failure; Risk Assessment; Sirolimus; Statistics, Nonparametric; Survival Rate; Time Factors; Treatment Outcome | 2013 |
Intra-individual head-to-head comparison of Sirolimus®- and Paclitaxel®-eluting stents for coronary revascularization. A randomized, multi-center trial.
Topics: Adult; Aged; Aged, 80 and over; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Observer Variation; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Sirolimus | 2013 |
Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Reference Values; Risk Assessment; Severity of Illness Index; Sirolimus; Survival Analysis; Time; Time Factors; Treatment Outcome | 2012 |
Retrospective comparison of midterm clinical and angiographic outcomes after the implantation of paclitaxel- and sirolimus-eluting stents for de novo coronary complex lesions in nonrandomized Japanese patients.
Topics: Aged; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome | 2012 |
Acute and long-term angiographic outcomes of side branch stenosis after randomized treatment of zotarolimus-, sirolimus-, and paclitaxel-eluting stent for coronary artery stenosis.
Topics: Acute Disease; Aged; Blood Vessels; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Odds Ratio; Paclitaxel; Predictive Value of Tests; Sirolimus; Thrombosis; Treatment Outcome | 2012 |
Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Feasibility Studies; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Paclitaxel; Stents; Treatment Outcome; Ultrasonography, Interventional | 2003 |
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Polymers; Risk; Stents | 2004 |
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.
Topics: Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Stents; Treatment Outcome | 2004 |
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
Topics: Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Polymers; Risk Factors; Stents; Treatment Outcome | 2004 |
Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
Topics: Antineoplastic Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Coronary Stenosis; Female; Humans; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Polymers; Stents; Treatment Outcome | 2005 |
Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I).
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Polymers; Stents; Treatment Outcome | 2005 |
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).
Topics: Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug Delivery Systems; Equipment Design; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Polymers; Prospective Studies; Stents; Time Factors; Tunica Intima; Ultrasonography, Interventional | 2005 |
Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation.
Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Risk Factors; Sirolimus; Stents; Treatment Outcome | 2005 |
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study).
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Calcinosis; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Paclitaxel; Severity of Illness Index; Stents; Time Factors; Treatment Outcome | 2005 |
Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE)
Topics: Combined Modality Therapy; Coronary Stenosis; Drug Delivery Systems; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Registries; Risk Factors; Stents | 2007 |
Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEA
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Registries; Sirolimus; Stents | 2006 |
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine | 2006 |
Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Female; Follow-Up Studies; Humans; Hyperplasia; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Radiography; Sirolimus; Stents; Tubulin Modulators; Tunica Intima; Ultrasonography, Interventional | 2007 |
Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Ultrasonography, Interventional | 2007 |
Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans.
Topics: Anti-Bacterial Agents; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Paclitaxel; Sirolimus; Stents; Treatment Outcome | 2007 |
Effect of preinterventional arterial remodeling on intimal hyperplasia after implantation of a polymer-based paclitaxel-eluting stent: angiographic and IVUS study.
Topics: Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Stenosis; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Preoperative Care; Prognosis; Retrospective Studies; Stents; Tunica Intima; Ultrasonography, Interventional | 2007 |
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.
Topics: Aged; Coronary Stenosis; Endpoint Determination; Equipment Design; Female; Humans; Male; Middle Aged; Neovascularization, Physiologic; Paclitaxel; Polymers; Prospective Studies; Stents; Tubulin Modulators | 2007 |
A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Paclitaxel; Stents; Treatment Outcome; Ultrasonography, Interventional | 2007 |
Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Double-Blind Method; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Probability; Proportional Hazards Models; Prospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Stents; Treatment Outcome | 2007 |
Effect of Paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Stenosis; Diabetic Angiopathies; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Korea; Male; Middle Aged; Paclitaxel; Prospective Studies; Secondary Prevention; Sirolimus; Treatment Outcome | 2008 |
Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Catheterization; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Equipment Design; Female; Humans; Male; Metals; Middle Aged; Netherlands; Paclitaxel; Prosthesis Design; Registries; Severity of Illness Index; Stents; Time Factors; Treatment Outcome | 2008 |
Clinical and angiographic results of angioplasty with a paclitaxel-eluting stent for unprotected left main coronary artery disease (a study of 101 consecutive patients).
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Feasibility Studies; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Time Factors; Treatment Outcome | 2008 |
206 other study(ies) available for paclitaxel and Coronary Stenosis
Article | Year |
---|---|
Short-Term and Long-Term Efficacy of Drug-Coated Balloon for In-Stent Restenosis in Hemodialysis Patients with Coronary Artery Disease.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Case-Control Studies; Cause of Death; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Hospitals, University; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Propensity Score; Renal Dialysis; Retrospective Studies; Risk Assessment; Survival Analysis; Time Factors; Treatment Outcome | 2019 |
Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Equipment Design; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Registries; Severity of Illness Index; Stents; Time Factors; Treatment Outcome | 2020 |
Paclitaxel crystals on the surface of a bioresorbable vascular scaffold visualized by optical coherence tomography after drug-eluting balloon angioplasty.
Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Metals; Paclitaxel; Prosthesis Failure; Retreatment; Stents; Tomography, Optical Coherence; Treatment Outcome | 2017 |
Angiographic study of the clinical liaison of drug-eluting stent and paclitaxel-eluting balloon in unifocal side branch ostium stenosis (ASCLEPIUS).
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Retrospective Studies; Time Factors; Treatment Outcome | 2017 |
Saphenous Vein Graft Aneurysm 10 Years After Paclitaxel-Eluting Stent Implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Aneurysm; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Paclitaxel; Saphenous Vein; Time Factors; Treatment Outcome | 2017 |
Dedicated bifurcation stents or regular drug eluting stents in distal left main stenosis: A retrospective study.
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Paclitaxel; Percutaneous Coronary Intervention; Poland; Postoperative Complications; Prosthesis Design; Retrospective Studies; Sirolimus; Survival Rate; Tissue Scaffolds; Treatment Outcome | 2018 |
Paclitaxel-coated balloon treatment for functionally nonsignificant residual coronary lesions after balloon angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Registries; Treatment Outcome | 2018 |
[Paclitaxel-coated balloons for in-stent restenosis treatment: long-term clinical results and predictors of recurrent target lesion revascularization].
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Italy; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Prognosis; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Assessment; Treatment Outcome; Vascular Patency | 2018 |
Plaque modification and stabilization after paclitaxel-coated balloon treatment for de novo coronary lesions.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Paclitaxel; Plaque, Atherosclerotic; Registries; Republic of Korea; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome | 2019 |
12-Month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm.
Topics: Aged; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Equipment Design; Feasibility Studies; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2019 |
Immediate and long-term results of a modified simultaneous kissing stenting for percutaneous coronary intervention of coronary artery bifurcation lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Metals; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Retrospective Studies; Sirolimus; Stents; Treatment Outcome | 2013 |
Impact of residual chronic total occlusion of right coronary artery on the long-term outcome in patients treated for unprotected left main disease: the Milan and New-Tokyo registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Coronary Circulation; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Death, Sudden, Cardiac; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Registries; Retrospective Studies; Tubulin Modulators | 2013 |
Thrombocytosis as a potential cause of a very late stent thrombosis in the left main coronary artery.
Topics: Adult; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Myocardial Infarction; Out-of-Hospital Cardiac Arrest; Paclitaxel; Thrombocytosis; Ticlopidine; Withholding Treatment | 2013 |
The "final voyage" of the Endeavor stent.
Topics: Cardiovascular Agents; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Metals; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus; Stents | 2013 |
Is there a need for distal protection during native vessel percutaneous coronary intervention in patients with stable coronary artery disease?
Topics: Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Embolic Protection Devices; Embolism; Humans; Male; Middle Aged; Paclitaxel; Patient Selection; Percutaneous Coronary Intervention; Predictive Value of Tests; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Spectroscopy, Near-Infrared; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional | 2014 |
Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis.
Topics: Aged; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Compassionate Use Trials; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Time Factors; Treatment Outcome | 2014 |
Combined paclitaxel-eluting balloon and Genous cobalt-chromium alloy stent utilization in de novo coronary stenoses (PEGASUS).
Topics: Angioplasty, Balloon, Coronary; Chromium Alloys; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Forecasting; Humans; Male; Middle Aged; Paclitaxel; Stents | 2013 |
Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Stenosis; Cross-Sectional Studies; Drug-Eluting Stents; Equipment Failure Analysis; Everolimus; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Prosthesis Failure; Sensitivity and Specificity; Sirolimus; Time Factors; Tomography, Optical Coherence | 2014 |
Inhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter.
Topics: Angioplasty, Balloon, Coronary; Animals; Antineoplastic Agents, Phytogenic; Cardiac Catheters; Coated Materials, Biocompatible; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Equipment Design; Hyperplasia; Male; Paclitaxel; Swine; Tunica Intima | 2014 |
Time dependency of outcomes for drug-eluting vs bare-metal stents.
Topics: Acute Coronary Syndrome; Aged; Alberta; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Stenosis; Drug-Eluting Stents; Equipment Failure; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Paclitaxel; Patient Outcome Assessment; Propensity Score; Proportional Hazards Models; Prospective Studies; Registries; Risk; Sirolimus; Stents; Survival Rate; Time Factors | 2013 |
Left main percutaneous coronary intervention: growing in maturity.
Topics: Cardiovascular Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Imaging, Three-Dimensional; Male; Paclitaxel; Percutaneous Coronary Intervention; Radiographic Image Interpretation, Computer-Assisted | 2013 |
Giant mycotic coronary aneurysm associated with late stent infection.
Topics: Aged; Aneurysm, Infected; Angioplasty, Balloon; Coronary Aneurysm; Coronary Stenosis; Device Removal; Drug-Eluting Stents; Echocardiography, Transesophageal; Emergency Treatment; Humans; Male; Paclitaxel; Prosthesis-Related Infections; Radiography; Rare Diseases; Risk Assessment; Treatment Outcome | 2014 |
Difference of neointimal growth patterns in bifurcation lesions among four kinds of drug-eluting stents: an optical coherence tomographic study.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Cross-Sectional Studies; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Paclitaxel; Prosthesis Failure; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional | 2014 |
Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study.
Topics: Acute Coronary Syndrome; Aged; Antineoplastic Agents; Cohort Studies; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Progression; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Sirolimus; Tomography, Optical Coherence | 2014 |
Dedicated bifurcation paclitaxel-eluting stent BiOSS Expert® in the treatment of distal left main stem stenosis.
Topics: Aged; Angina, Stable; Angioplasty; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Treatment Outcome | 2014 |
Long-term safety and efficacy of the everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice.
Topics: Aged; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Sirolimus; Treatment Outcome | 2014 |
Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Cohort Studies; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Graft Occlusion, Vascular; Hospital Mortality; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Registries; Retrospective Studies; Severity of Illness Index; Sirolimus; Survival Analysis; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Withholding Treatment | 2014 |
Propensity score-matched lesion-based comparison of mid-term angiographic outcomes of TAXUS Liberté with Cypher Bx Velocity stents for de novo native coronary stenosis and in patients with diabetes.
Topics: Aged; Antineoplastic Agents; Coronary Angiography; Coronary Stenosis; Diabetes Complications; Diabetic Angiopathies; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Odds Ratio; Paclitaxel; Percutaneous Coronary Intervention; Propensity Score; Retrospective Studies; Sirolimus; Treatment Outcome | 2014 |
Drug-coated balloon after coronary stenting falls short.
Topics: Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Endothelium, Vascular; Female; Humans; Male; Metals; Paclitaxel; Sirolimus; Stents | 2014 |
Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center.
Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Iowa; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Retrospective Studies; Risk Factors; Sex Factors; Sirolimus; Tertiary Care Centers; Time Factors; Treatment Outcome | 2014 |
A lipid nanoemulsion carrying paclitaxel improves the gene expression of inflammatory factors of heart grafts in rabbits.
Topics: Animals; Cardiovascular Agents; Coronary Stenosis; Drug Carriers; Emulsions; Heart Transplantation; Male; Nanoparticles; Paclitaxel | 2014 |
Will drug coated balloons score another victory?
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiac Catheters; Coated Materials, Biocompatible; Coronary Stenosis; Coronary Vessels; Male; Paclitaxel; Tunica Intima | 2014 |
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE).
Topics: Aged; Cardiovascular Diseases; Chromium; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Platinum; Product Surveillance, Postmarketing; Prospective Studies; Reoperation; Treatment Failure; Treatment Outcome; Tubulin Modulators | 2015 |
Long-term angiographic outcomes of sirolimus- and paclitaxel-eluting stent placement in diabetes, long lesions, and small vessels.
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Paclitaxel; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome | 2015 |
Slow-flow phenomenon after Paclitaxel-coated balloon angioplasty: findings from optical coherence tomography and coronary angioscopy.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Angioscopy; Coronary Angiography; Coronary Circulation; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Monitoring, Physiologic; No-Reflow Phenomenon; Paclitaxel; Prosthesis Failure; Retreatment; Sampling Studies; Severity of Illness Index; Stents; Tomography, Optical Coherence; Treatment Outcome | 2015 |
Six month angiographic result of supplementary paclitaxel-eluting balloon deployment to treat side branch ostium narrowing (SARPEDON).
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Registries; Tubulin Modulators | 2015 |
The STENTYS Self-Apposing® stent.
Topics: Alloys; Antineoplastic Agents; Coronary Stenosis; Drug-Eluting Stents; Humans; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus; Stents; Treatment Outcome | 2015 |
The Nile CroCo and Nile PAX stents.
Topics: Antineoplastic Agents, Phytogenic; Chromium Alloys; Coronary Stenosis; Drug-Eluting Stents; Humans; Paclitaxel; Percutaneous Coronary Intervention; Stents; Treatment Outcome | 2015 |
The BiOSS stent.
Topics: Antineoplastic Agents; Coronary Stenosis; Drug-Eluting Stents; Humans; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus; Stainless Steel; Treatment Outcome | 2015 |
Neoatherosclerosis: mirage of an ancient illness or genuine disease condition?
Topics: Coronary Stenosis; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Paclitaxel | 2015 |
Serial changes of coronary endothelial function and arterial healing after paclitaxel-eluting stent implantation.
Topics: Acetylcholine; Aged; Angina, Stable; Angioscopy; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroglycerin; Paclitaxel; Percutaneous Coronary Intervention; Tunica Intima; Vasodilator Agents | 2016 |
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Constriction, Pathologic; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Registries; Sirolimus; Time; Treatment Outcome | 2016 |
Comparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry).
Topics: Aged; Angiography; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Poland; Proportional Hazards Models; Registries; Retrospective Studies; Sirolimus; Stents; Thrombosis; Treatment Outcome | 2015 |
Paclitaxel-coated balloon exerts late vessel healing and enlargement: A documented phenomenon with optical coherence tomography analysis.
Topics: Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Radiography; Tomography, Optical Coherence | 2016 |
Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Equipment Design; Female; France; Graft Occlusion, Vascular; Humans; Male; Paclitaxel; Prospective Studies; Registries; Reoperation; Treatment Outcome | 2016 |
Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies | 2016 |
Serial Morphological Changes of Side-Branch Ostium after Paclitaxel-Coated Balloon Treatment of De Novo Coronary Lesions of Main Vessels.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Tubulin Modulators | 2016 |
Serial Morphological and Functional Assessment of the Paclitaxel-coated Balloon for de Novo Lesions.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome | 2016 |
Long-term comparative effectiveness of paclitaxel-eluting and everolimus-eluting stents in New York.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; New York; Paclitaxel; Propensity Score; Proportional Hazards Models; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Time Factors; Treatment Outcome | 2017 |
Safety of bailout stenting after paclitaxel-coated balloon angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Paclitaxel; Patient Safety; Postoperative Complications; Reoperation; Retrospective Studies; Singapore; Stents | 2017 |
Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Female; Inflammation; Male; Metals; Nitroglycerin; Paclitaxel; Swine; Vasodilation | 2009 |
Comparison of one-year clinical outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice.
Topics: Aged; Blood Vessel Prosthesis; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Stents; Treatment Outcome | 2008 |
Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Odds Ratio; Paclitaxel; Retrospective Studies; Risk Assessment; Sirolimus; Time Factors; Treatment Outcome | 2008 |
Comparison of sirolimus-eluting stent and paclitaxel-eluting stent for long-term cardiac adverse events in diabetic patients: the Korean Multicenter Angioplasty Team (KOMATE) Registry.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Stenosis; Diabetes Complications; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Korea; Male; Middle Aged; Paclitaxel; Registries; Risk Assessment; Sirolimus; Time Factors; Treatment Outcome | 2008 |
Direct stenting versus predilatation and stenting technique when using paclitaxel-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Drug-Eluting Stents; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Radiography; Retrospective Studies; Treatment Outcome; Tubulin Modulators | 2008 |
Experience with paclitaxel-eluting Infinnium coronary stents.
Topics: Angioplasty, Balloon, Coronary; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Cardiovascular Agents; Cardiovascular Diseases; Coronary Stenosis; Drug-Eluting Stents; Electrocardiography; Exercise Test; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Registries; Time Factors; Treatment Outcome | 2008 |
Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Everolimus; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Insulin; Meta-Analysis as Topic; Metals; Paclitaxel; Patient Selection; Prosthesis Design; Randomized Controlled Trials as Topic; Registries; Risk Assessment; Sirolimus; Thrombosis; Treatment Outcome | 2008 |
Drug-eluting balloons for percutaneous coronary interventions.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Coronary Stenosis; Coronary Vessels; Equipment Design; Humans; Metals; Models, Animal; Paclitaxel; Stents; Sus scrofa | 2009 |
Drug-eluting balloon: very short-term exposure and overlapping.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Equipment Design; Materials Testing; Metals; Models, Animal; Paclitaxel; Stents; Sus scrofa | 2009 |
Retrograde embolization after balloon angioplasty in a patient with late stent subthrombosis in a paclitaxel-eluting stent.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Paclitaxel; Platelet Aggregation Inhibitors; Time Factors | 2008 |
Intimal proliferation and restenosis in paclitaxel-eluting stents with aminoparylene as carrier substance in swines.
Topics: Animals; Cell Proliferation; Chromium Alloys; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug Hypersensitivity; Drug-Eluting Stents; Incidence; Metals; Paclitaxel; Polymers; Stents; Swine; Tunica Intima; Xylenes | 2009 |
Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents--results of the multicentre FRIEND registry.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; France; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Registries; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome.
Topics: Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Stenosis; Drug-Eluting Stents; Follow-Up Studies; Hospital Mortality; Humans; Kaplan-Meier Estimate; Middle Aged; Odds Ratio; Paclitaxel; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Stroke Volume; Time Factors; Treatment Outcome | 2009 |
Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Electrocardiography; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prosthesis Design; Retrospective Studies; Sirolimus; Time Factors; Ultrasonography, Interventional; Vasoconstriction | 2008 |
The process of bringing new drug-eluting stents to market will they see the light of day?
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Humans; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2008 |
Drug-eluting coronary stents: many meta-analyses, little benefit.
Topics: Angina, Unstable; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Hypersensitivity; Meta-Analysis as Topic; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Ticlopidine; Treatment Outcome | 2009 |
Advanced neointimal growth is not associated with a low risk of in-stent thrombus. Optical coherence tomographic findings after first-generation drug-eluting stent implantation.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Tunica Intima | 2009 |
Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2009 |
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States | 2009 |
Percutaneous treatment with drug-eluting stent vs bypass surgery in patients suffering from chronic stable angina with multivessel disease involving significant proximal stenosis in left anterior descending artery.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cerebrovascular Disorders; Chronic Disease; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Registries; Reoperation; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Comparison of chronic-stage histopathological findings among 3 coronary stents implanted in the same patient.
Topics: Aged; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Paclitaxel; Radiography; Sirolimus; Stents | 2011 |
Parameter estimation methodology in a model of hydrophobic drug release from a polymer coating.
Topics: Coated Materials, Biocompatible; Coronary Stenosis; Drug Carriers; Drug-Eluting Stents; Humans; Hydrophobic and Hydrophilic Interactions; Microscopy, Atomic Force; Models, Biological; Osmosis; Paclitaxel; Solubility; Styrenes | 2010 |
Three year follow-up of the sirolimus-eluting stent and the paclitaxel-eluting stent in daily practice.
Topics: Angioplasty, Balloon, Coronary; Cardiotonic Agents; China; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Sirolimus | 2009 |
First clinical experience of "flower petal stenting": a novel technique for the treatment of coronary bifurcation lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Endoscopy; Female; Humans; Male; Materials Testing; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Severity of Illness Index; Sirolimus; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Interventional | 2010 |
The artisan approach for stenting bifurcation lesions.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Paclitaxel; Prosthesis Design; Sirolimus; Time Factors; Treatment Outcome | 2010 |
Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: a Canadian experience.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Ontario; Paclitaxel; Retrospective Studies; Time Factors; Treatment Outcome | 2010 |
Sirolimus- versus paclitaxel-eluting stents for the treatment of cardiac allograft vasculopathy.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Heart Transplantation; Humans; Italy; Los Angeles; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Retrospective Studies; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Transplantation, Homologous; Treatment Outcome | 2010 |
Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis.
Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Incidence; Male; Middle Aged; Paclitaxel; Probability; Registries; Risk Assessment; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional | 2010 |
Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
Topics: Absorbable Implants; Animals; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Eluting Stents; Hyperplasia; Materials Testing; Paclitaxel; Polyesters; Swine; Tunica Intima | 2010 |
Sirolimus versus paclitaxel coronary stents in clinical practice.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Switzerland; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Stenosis; Coronary Thrombosis; Death, Sudden, Cardiac; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Registries; Risk Factors; Sirolimus | 2011 |
Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cohort Studies; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Outcome | 2010 |
Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cerebrovascular Disorders; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Health Status Indicators; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Registries; Reproducibility of Results; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2010 |
Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; China; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Health Status Indicators; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; ROC Curve; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Drug-eluting balloons: what is their place on the interventionalist's shelf?
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Drug-Eluting Stents; Equipment Design; Humans; Paclitaxel | 2010 |
Crush stenting with drug-eluting stents: relevance of coronary bifurcation lesion location on angiographic and clinical outcomes.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; China; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2010 |
Two-year clinical outcomes after large coronary stent (4.0 mm) placement: comparison of bare-metal stent versus drug-eluting stent.
Topics: Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Postoperative Period; Prosthesis Design; Retrospective Studies; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome; Tubulin Modulators | 2010 |
High glycemic stenting menu.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Humans; Hypoglycemic Agents; Insulin; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Clinical characteristics of coronary drug-eluting stent fracture: insights from a two-center des registry.
Topics: Age Factors; Aged; Cardiovascular Agents; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Registries; Risk Factors; Sex Factors; Sirolimus | 2011 |
Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Radiography; Registries; Risk Assessment; Sirolimus; Survival Analysis; Time Factors | 2011 |
Predictors of edge stenosis after paclitaxel-eluting stent implantation.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Paclitaxel; Republic of Korea; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis.
Topics: Angioplasty, Balloon; Animals; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Fibrin; Humans; Neointima; Paclitaxel; Swine; Wound Healing | 2011 |
If I've heard it once, I've heard it (not yet) a hundred times.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Myocardial Infarction; Paclitaxel; Patient Selection; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
An artificial nanoemulsion carrying paclitaxel decreases the transplant heart vascular disease: a study in a rabbit graft model.
Topics: Analysis of Variance; Animals; Cardiovascular Agents; Coronary Stenosis; Drug Carriers; Emulsions; Graft Rejection; Graft Survival; Heart Transplantation; Lipids; Macrophages; Male; Myocardium; Nanoparticles; Paclitaxel; Rabbits; Severity of Illness Index; Time Factors | 2011 |
Acute vasomotor paralysis and potential downstream effects of paclitaxel from stents implanted for saphenous vein aorto-coronary bypass stenosis.
Topics: Aged; Animals; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Rats; Rats, Inbred Lew; Saphenous Vein; Serotonin; Thromboxane B2; Vasoconstriction | 2011 |
Comparison of everolimus-eluting stent with paclitaxel-eluting stent in long chronic total occlusions.
Topics: Aged; Chronic Disease; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease-Free Survival; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Paclitaxel; Sirolimus; Treatment Outcome | 2011 |
Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.
Topics: Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Ontario; Paclitaxel; Prosthesis Design; Prosthesis Failure; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2012 |
"Sirolimus or paclitaxel drug eluting stent in left main disease: the winner is... ".
Topics: Angioplasty, Balloon, Coronary; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Sirolimus | 2011 |
Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cerebrovascular Disorders; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease-Free Survival; Drug-Eluting Stents; Female; France; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome | 2011 |
Catheter based local delivery of fluid paclitaxel: the Tübingen experience.
Topics: Aged; Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Catheters; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Equipment Design; Germany; Humans; Middle Aged; Paclitaxel; Prosthesis Design; Radiography; Stents; Treatment Outcome | 2011 |
Response to "Sirolimus or paclitaxel drug eluting stent in left main disease: the winner is...".
Topics: Angioplasty, Balloon, Coronary; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Sirolimus | 2012 |
Second-generation everolimus-eluting stents and the beat goes on?
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Paclitaxel; Sirolimus | 2011 |
Better stent expansion by two-time inflation of stent balloon and its responsible mechanism.
Topics: Aged; Angioplasty, Balloon, Coronary; Catheterization; Coronary Stenosis; Drug-Eluting Stents; Endosonography; Equipment Design; Female; Humans; Insufflation; Male; Paclitaxel; Sirolimus; Stents | 2012 |
First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Poland; Prosthesis Design; Time Factors; Treatment Outcome; Tubulin Modulators | 2012 |
[Comment to article Bifurkacja - odbicie rzeczywistości fraktalnej].
Topics: Blood Vessel Prosthesis Implantation; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Tubulin Modulators | 2012 |
Fixing a broken stent.
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Prosthesis Failure; Sirolimus | 2012 |
Paclitaxel versus sirolimus eluting stents in diabetic patients: does stent type and/or stent diameter matter?: long-term clinical outcome of 2,429-patient multicenter registry.
Topics: Aged; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Patient Safety; Proportional Hazards Models; Prosthesis Design; Prosthesis Failure; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Survival Rate; Time Factors; Treatment Outcome | 2013 |
Choice of stent and outcomes after treatment of drug-eluting stent restenosis in highly complex lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Ontario; Paclitaxel; Patient Selection; Prosthesis Failure; Registries; Retreatment; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Survival Analysis; Treatment Outcome | 2013 |
Everolimus-induced pneumonitis after drug-eluting stent implantation: a case report.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Follow-Up Studies; Humans; Male; Paclitaxel; Pneumonia; Prednisolone; Radiography, Thoracic; Retreatment; Risk Assessment; Sirolimus; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry.
Topics: Aged; Aged, 80 and over; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Equipment Failure; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Registries; Risk Factors; Treatment Outcome | 2012 |
Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Angina, Stable; Cardiovascular Agents; Coronary Stenosis; Coronary Thrombosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Poland; Polymers; Propensity Score; Prosthesis Design; Registries; Retrospective Studies; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2013 |
Sequential use of bare-metal stents and drug-coated balloons to treat coronary artery stenosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Registries; Retrospective Studies; Stents; Treatment Outcome | 2012 |
Qualitative and quantitative assessment of stent restenosis by optical coherence tomography: comparison between drug-eluting and bare-metal stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Incidence; Male; Metals; Middle Aged; Neointima; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome | 2013 |
[Position paper on the use of drug eluting stents (DES) in percutaneous coronary interventions in patients with coronary heart disease].
Topics: Angioplasty, Balloon, Coronary; Animals; Coated Materials, Biocompatible; Coronary Stenosis; Cost-Benefit Analysis; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2003 |
[Are drug-coated stents too expensive?].
Topics: Antineoplastic Agents; Cell Division; Coronary Stenosis; Delayed-Action Preparations; Germany; Humans; Immunosuppressive Agents; Paclitaxel; Secondary Prevention; Sirolimus; Stents | 2003 |
Risk of noncardiac surgery in the months following placement of a drug-eluting coronary stent.
Topics: Coronary Stenosis; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Surgical Procedures, Operative; Thrombosis; Time Factors | 2004 |
"Candy wrapper" effect after drug-eluting stent implantation: déjà vu or stumbling over the same stone again?
Topics: Aged; Brachytherapy; Coronary Restenosis; Coronary Stenosis; Humans; Male; Paclitaxel; Stents; Ultrasonography | 2004 |
A chicken in every pot and a drug-eluting stent in every lesion.
Topics: Aged; Angioplasty, Balloon; Clinical Trials as Topic; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Humans; Male; Paclitaxel; Stents | 2004 |
How many grails do we need?
Topics: Combined Modality Therapy; Coronary Restenosis; Coronary Stenosis; Drug Implants; Everolimus; Follow-Up Studies; Growth Inhibitors; Humans; Immunosuppressive Agents; Paclitaxel; Pilot Projects; Randomized Controlled Trials as Topic; Single-Blind Method; Sirolimus; Stents; Treatment Outcome | 2004 |
Paclitaxel-eluting coronary stents.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Pyridines; Stents; Thrombosis; Ticlopidine | 2004 |
Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes.
Topics: Aged; Angioplasty, Balloon, Coronary; Brachytherapy; Cohort Studies; Combined Modality Therapy; Coronary Restenosis; Coronary Stenosis; Disease-Free Survival; Drug Implants; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Incidence; Male; Middle Aged; Paclitaxel; Radiography; Recurrence; Sirolimus; Stents; Treatment Outcome | 2004 |
Remise in the treatment of in-stent restenosis.
Topics: Coronary Stenosis; Drug Implants; Humans; Paclitaxel; Stents | 2004 |
Contemporary treatment of small-vessel disease.
Topics: Angioplasty, Balloon, Coronary; Coronary Stenosis; Coronary Vessels; Drug Delivery Systems; Humans; Paclitaxel; Sirolimus; Stents | 2004 |
["Active" endoprosthesis with in situ release of an antimitotic or cytostatic drug: a revolution that cannot do without thought].
Topics: Antineoplastic Agents; Combined Modality Therapy; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Everolimus; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Sirolimus; Stents | 2004 |
Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.
Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug Evaluation, Preclinical; Paclitaxel; Stents; Sus scrofa; Tunica Intima | 2004 |
[A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. Results of TAXUS IV].
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Delayed-Action Preparations; Double-Blind Method; Follow-Up Studies; Humans; Paclitaxel; Polymers; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Stents; Time Factors; Treatment Outcome | 2004 |
Delayed severe multivessel spasm and aborted sudden death after Taxus stent implantation.
Topics: Blood Vessel Prosthesis; Coronary Stenosis; Coronary Vasospasm; Death, Sudden, Cardiac; Delayed-Action Preparations; Drug Implants; Female; Humans; Middle Aged; Nitroglycerin; Paclitaxel; Risk Factors; Stents; Vasodilator Agents | 2005 |
Cost-effectiveness of drug-eluting stents: if only all things were equal.
Topics: Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Australia; Cell Proliferation; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Stenosis; Cost-Benefit Analysis; Humans; Outcome Assessment, Health Care; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2005 |
Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era.
Topics: Acute Disease; Anticoagulants; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug Therapy, Combination; Electrocardiography; Female; Heparin; Humans; Intraoperative Complications; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Predictive Value of Tests; Pyridines; Retrospective Studies; Stents; Thrombolytic Therapy; Ticlopidine; Treatment Outcome | 2005 |
Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry.
Topics: Antineoplastic Agents, Phytogenic; Chronic Disease; Coronary Angiography; Coronary Stenosis; Delayed-Action Preparations; Drug Implants; Female; Humans; Male; Middle Aged; Paclitaxel; Polymers; Prospective Studies; Registries; Stents; Treatment Outcome | 2005 |
Sirolimus- versus paclitaxel-eluting stent implantation for unprotected left main coronary artery stenosis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Multimodality plaque ablation following failure of conventional wires and balloons to cross and to allow successful paclitaxel-eluting stent implantation of a chronic total occlusion.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Coronary Stenosis; Humans; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Stents; Treatment Failure | 2005 |
Seeing transient regional myocardial ischaemia through new eyes.
Topics: Aged; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Body Surface Potential Mapping; Coated Materials, Biocompatible; Coronary Stenosis; Humans; Image Processing, Computer-Assisted; Male; Myocardial Ischemia; Myocardial Reperfusion; Paclitaxel; Stents | 2005 |
Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions.
Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Retrospective Studies; Severity of Illness Index; Sirolimus; Stents; Survival Rate; Time Factors; Treatment Outcome | 2005 |
[Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
Topics: Angioplasty, Balloon, Coronary; Controlled Clinical Trials as Topic; Coronary Restenosis; Coronary Stenosis; Drug Implants; Humans; Immunosuppressive Agents; Myocardial Revascularization; Paclitaxel; Sirolimus; Stents | 2005 |
Procedural success and 30 day outcomes between CYPHER and TAXUS stent implantation for the treatment of bifurcation lesions--a single-center experience.
Topics: Acute Disease; Aged; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Registries; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2006 |
Role of drug eluting stents in diabetic patients.
Topics: Catheterization; Coronary Stenosis; Diabetic Angiopathies; Drug Implants; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents | 2006 |
Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
Topics: Aged; Angioplasty, Balloon, Coronary; Case-Control Studies; Chi-Square Distribution; Chronic Disease; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Logistic Models; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Sirolimus; Stents; Treatment Outcome | 2006 |
Is late luminal loss an accurate predictor of the clinical effectiveness of drug-eluting stents in the coronary arteries?
Topics: Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Humans; Immunosuppressive Agents; Paclitaxel; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Failure; Treatment Outcome | 2006 |
Successful management of left main coronary artery stenosis with a paclitaxel-eluting stent in Takayasu's arteritis.
Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Stenosis; Female; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents; Takayasu Arteritis; Treatment Outcome | 2006 |
Comparison of the effectiveness of sirolimus- and paclitaxel-eluting stents for small coronary artery lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Radiography; Reoperation; Retrospective Studies; Sirolimus; Stents; Treatment Outcome | 2006 |
A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
Topics: Analysis of Variance; Animals; Carbon; Chromium; Coated Materials, Biocompatible; Cobalt; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Lactic Acid; Nanostructures; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Stents; Swine | 2006 |
Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy.
Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Reoperation; Sirolimus; Stents; Survival Analysis; Treatment Outcome | 2006 |
Bifurcation stenting with drug eluting stents: illustration of the crush technique.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Middle Aged; Paclitaxel; Sirolimus; Stents; Treatment Outcome | 2006 |
Images in cardiovascular medicine. Implantation of a drug-eluting stent for the coronary artery stenosis of Takayasu arteritis: de novo and in-stent restenosis.
Topics: Adult; Blood Sedimentation; C-Reactive Protein; Coronary Stenosis; Female; Humans; Paclitaxel; Stents; Takayasu Arteritis; Ultrasonography, Interventional | 2006 |
Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Coronary Stenosis; Drug Implants; Endoscopy; Feasibility Studies; Female; Humans; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Prospective Studies; Sirolimus; Stents; Treatment Outcome | 2006 |
Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prognosis; Sirolimus; Stents; Time Factors; Treatment Outcome | 2006 |
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Collateral Circulation; Coronary Angiography; Coronary Circulation; Coronary Restenosis; Coronary Stenosis; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Stents | 2006 |
Spontaneous resolution of neoaneurysm following implantation of a paclitaxel-eluting coronary stent.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Aneurysm; Coronary Angiography; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Middle Aged; Paclitaxel; Remission, Spontaneous; Stents | 2006 |
Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries.
Topics: Absorbable Implants; Animals; Coronary Stenosis; Coronary Vessels; Drug Delivery Systems; Equipment Design; Muscle, Smooth, Vascular; Necrosis; Paclitaxel; Polymers; Stents; Swine; Tunica Intima; Ultrasonography, Interventional | 2006 |
Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study.
Topics: Aged; Chronic Disease; Coronary Disease; Coronary Stenosis; Diabetic Angiopathies; Drug Delivery Systems; Equipment Design; Female; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Male; Metals; Middle Aged; Multicenter Studies as Topic; Paclitaxel; Prolapse; Randomized Controlled Trials as Topic; Risk Assessment; Sirolimus; Stents; Treatment Outcome; Ultrasonography, Interventional | 2006 |
Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions.
Topics: Adult; Aged; Aged, 80 and over; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Korea; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Revascularization; Outcome Assessment, Health Care; Paclitaxel; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Ventricular Dysfunction, Left | 2006 |
An unusual echodensity in the ascending aorta: transesophageal echocardiographic visualization of a protruding coronary stent.
Topics: Aged; Aorta; Coronary Artery Bypass; Coronary Stenosis; Echocardiography, Transesophageal; Female; Humans; Paclitaxel; Stents | 2006 |
Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry.
Topics: Aged; Coronary Stenosis; Data Collection; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Prospective Studies; Registries; Sirolimus; Stents; Treatment Outcome | 2006 |
Polymer-based paclitaxel-eluting stents are superior to nonpolymer-based paclitaxel-eluting stents in the treatment of de novo coronary lesions.
Topics: Coronary Angiography; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Recurrence; Stents; Survival Rate; Treatment Outcome; Tubulin Modulators; Ultrasonography, Interventional | 2006 |
Risk of noncardiac surgery after coronary drug-eluting stent implantation.
Topics: Aged; Coronary Stenosis; Humans; Male; Middle Aged; Paclitaxel; Risk Factors; Sirolimus; Stents; Surgical Procedures, Operative; Texas; Treatment Outcome | 2006 |
Critics say drug-eluting stents overused.
Topics: Angioplasty, Balloon, Coronary; Coronary Stenosis; Humans; Immunosuppressive Agents; Paclitaxel; Risk; Sirolimus; Stents | 2006 |
Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries.
Topics: Aged; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Male; Middle Aged; Netherlands; Paclitaxel; Proportional Hazards Models; Prospective Studies; Registries; Sirolimus; Stents; Treatment Outcome | 2007 |
[Coronary stents and anaesthesia: it is time to have national data].
Topics: Aged; Aged, 80 and over; Anesthesia, General; Coronary Restenosis; Coronary Stenosis; Drug Implants; Female; France; Hematoma; Humans; Incidence; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Registries; Sirolimus; Stents; Surgical Procedures, Operative; Thrombophilia; Thrombosis | 2007 |
Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients.
Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Female; Follow-Up Studies; Humans; Italy; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Registries; Regression Analysis; Research Design; Severity of Illness Index; Stents; Treatment Outcome; Vascular Patency | 2007 |
Utility of three-dimensional reconstruction of coronary angiography to guide percutaneous coronary intervention.
Topics: Algorithms; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Humans; Image Processing, Computer-Assisted; Immunosuppressive Agents; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Research Design; Sirolimus; Stents; Treatment Outcome | 2007 |
Target lesion revascularisation in patients treated with a sirolimus-eluting or paclitaxel-eluting stent.
Topics: Analysis of Variance; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Denmark; Drug Delivery Systems; Equipment Design; Humans; Logistic Models; Paclitaxel; Registries; Risk Factors; Sirolimus; Stents; Treatment Outcome | 2007 |
One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Registries; Reoperation; Research Design; Spain; Stents; Time Factors; Treatment Outcome | 2007 |
Simultaneous kissing stent technique to treat left main stem bifurcation disease.
Topics: Aged; Animals; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Stents; Swine; Treatment Outcome | 2007 |
Coronary collateral function long after drug-eluting stent implantation.
Topics: Aged; Chemotactic Factors; Collateral Circulation; Coronary Stenosis; Coronary Vessels; Cytokines; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Paclitaxel; Sirolimus; Stents | 2007 |
Emerging thrombotic effects of drug eluting stents.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Delivery Systems; Endothelium, Vascular; Humans; Mice; Mice, Transgenic; Paclitaxel; Plasminogen Activator Inhibitor 1; Risk Factors; RNA, Messenger; Sirolimus; Stents; Tissue Plasminogen Activator; Up-Regulation | 2007 |
Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.
Topics: Administration, Sublingual; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vasospasm; Diagnosis, Differential; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroglycerin; Paclitaxel; Postoperative Complications; Stents; Time Factors; Treatment Outcome; Vasoconstriction; Vasodilator Agents | 2007 |
Double barrel stenting of the left main: proceed with caution.
Topics: Aged; Animals; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Stents; Swine; Treatment Outcome | 2007 |
Comparison of angiographic patterns of in-stent restenosis between sirolimus- and paclitaxel-eluting stent.
Topics: Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Prospective Studies; Sirolimus; Stents | 2007 |
Polymer-based paclitaxel-eluting stents implantation in unprotected left main.
Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Stenosis; Humans; Paclitaxel; Polymers; Registries; Stents | 2007 |
Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents.
Topics: Aged; Cohort Studies; Coronary Angiography; Coronary Stenosis; Endothelium, Vascular; Female; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; Time Factors; Tubulin Modulators | 2007 |
[Drug eluting stents: long term results in clinical practice. Comparison between rapamycin and paclitaxel eluting stents].
Topics: Combined Modality Therapy; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Male; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Time Factors | 2007 |
Frequency of coronary arterial late angiographic stent thrombosis (LAST) in the first six months: outcomes with drug-eluting stents versus bare metal stents.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Incidence; Korea; Male; Middle Aged; Paclitaxel; Postoperative Period; Risk Factors; Sirolimus; Stents; Treatment Outcome | 2007 |
Proximal left anterior descending coronary artery revascularization with drug-eluting stents.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug Implants; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Prognosis; Sirolimus; Stents; Survival Analysis; Treatment Outcome | 2007 |
Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes.
Topics: Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Stenosis; Coronary Vessel Anomalies; Drug Delivery Systems; Female; Heart Defects, Congenital; Humans; Male; Myocardial Infarction; Paclitaxel; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Stents; Survival Analysis; Time Factors; Treatment Outcome; Vascular Patency | 2007 |
Coronary artery aneurysms associated with a Paclitaxel coated stent.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Chest Pain; Coronary Aneurysm; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Paclitaxel; Risk Assessment; Treatment Outcome | 2008 |
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Diabetes Mellitus; Drug Implants; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Registries; Renal Insufficiency; Risk Factors; Sirolimus; Stents; Ticlopidine; Treatment Outcome | 2007 |
Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents.
Topics: Adult; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Paclitaxel; Stents; Treatment Outcome | 2007 |
Vascular pathology as a result of drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Cell Proliferation; Coronary Restenosis; Coronary Stenosis; Drug Implants; Humans; Muscle, Smooth, Vascular; Paclitaxel; Sirolimus; Stents; Tunica Intima | 2007 |
Culotte versus T-stenting in bifurcation lesions: immediate clinical and angiographic results and midterm clinical follow-up.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Stenosis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Stents | 2007 |
Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Coronary Vessels; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Sirolimus; Stents | 2007 |
Coronary dilatation 10 weeks after paclitaxel-eluting stent implantation. No role of shear stress in lumen enlargement?
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Equipment Failure Analysis; Fibromuscular Dysplasia; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Middle Aged; Paclitaxel; Shear Strength; Tunica Intima; Ultrasonography, Interventional; Vasodilation | 2007 |
Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Disease Progression; Drug Hypersensitivity; Drug Therapy, Combination; Exanthema; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Tubulin Modulators; Urticaria | 2007 |
The changing face of angiographic patterns of restenosis after drug-eluting stent placement: sirolimus versus paclitaxel-eluting stent.
Topics: Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus | 2008 |
Left main drug-eluting stents: natural progression or a bridge too far?
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coronary Artery Bypass; Coronary Stenosis; Drug Delivery Systems; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Stents; Treatment Outcome | 2007 |
Differences in utilization of drug-eluting stents by race and payer.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Black or African American; Coronary Stenosis; Databases, Factual; Drug Delivery Systems; Drug-Eluting Stents; Female; Health Services Accessibility; Healthcare Disparities; Humans; Insurance, Health; Male; Medicaid; Medicare; Middle Aged; Minority Groups; New York; Paclitaxel; Platelet Aggregation Inhibitors; Socioeconomic Factors; United States; Vulnerable Populations | 2007 |
Retrograde application of the buddy wire technique.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Humans; Male; Paclitaxel; Stents | 2007 |
Late coronary stent thrombosis complicating urologic surgery.
Topics: Aged; Clopidogrel; Coronary Stenosis; Drug-Eluting Stents; Fatal Outcome; Humans; Immunosuppressive Agents; Lymph Node Excision; Male; Paclitaxel; Platelet Aggregation Inhibitors; Prostatic Neoplasms; Thrombosis; Ticlopidine; Withholding Treatment | 2008 |
Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction.
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Stenosis; Endothelium, Vascular; Equipment Design; Female; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Radiography; Sirolimus; Stents; Treatment Outcome; Tubulin Modulators; Vasoconstriction; Vasodilation | 2007 |
Evaluation of the dedicated Frontier coronary bifurcation stent: A matched pair analysis with drug-eluting and bare metal stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Stenosis; Drug Delivery Systems; Drug-Eluting Stents; Equipment Design; Female; Humans; Male; Matched-Pair Analysis; Metals; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Treatment Outcome | 2008 |
Very late restenosis after paclitaxel-eluting stent implantation.
Topics: Aged; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Male; Paclitaxel; Radiography; Saphenous Vein; Time Factors | 2007 |
Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry.
Topics: Aged; Coated Materials, Biocompatible; Comorbidity; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Registries | 2008 |
Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Paclitaxel; Prospective Studies; Registries; Sirolimus; Stents; Treatment Outcome | 2008 |
B-type natriuretic peptide as a marker of asymptomatic re-stenosis after coronary implantation of a paclitaxel-eluting stent.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Paclitaxel; Predictive Value of Tests; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2007 |
Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions.
Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Polymers; Probability; Prognosis; Reference Values; Risk Assessment; Severity of Illness Index; Sirolimus; Survival Analysis; Treatment Outcome; Vascular Patency; Vasodilator Agents | 2008 |
Drug for a while, polymer for life: Is it a good solution?
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Polymers; Prognosis; Radiography; Risk Assessment; Sensitivity and Specificity; Sirolimus; Survival Analysis; Treatment Outcome | 2008 |
Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis.
Topics: Animals; Cell Proliferation; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Female; Hyperplasia; Inflammation; Paclitaxel; Sirolimus; Stents; Swine; Tunica Intima | 2008 |
Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
Topics: Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Electrocardiography; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Myocardial Revascularization; Paclitaxel; Prospective Studies; Sirolimus; Stents; Treatment Outcome; Tubulin Modulators; Ultrasonography, Interventional | 2008 |
Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis?
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cineangiography; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Equipment Failure Analysis; Female; Humans; Incidental Findings; Male; Middle Aged; Odds Ratio; Paclitaxel; Prosthesis Design; Prosthesis Failure; Research Design; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Wisconsin | 2008 |
Stent strut fracture: seeing is believing.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cineangiography; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Incidental Findings; Paclitaxel; Prosthesis Design; Prosthesis Failure; Risk Assessment; Risk Factors; Sirolimus; Stress, Mechanical; Time Factors; Treatment Outcome | 2008 |
Stenting for unprotected left main coronary artery stenosis: a further step.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Time Factors; Treatment Outcome | 2008 |
Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Treatment Outcome | 2008 |
New tools for prevention of restenosis could decrease the "oculo-stento" reflex.
Topics: Angioplasty, Balloon, Coronary; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Coronary Restenosis; Coronary Stenosis; Docetaxel; Drug Implants; Humans; Injections, Intra-Arterial; Models, Animal; Paclitaxel; Rabbits; Rats; Sirolimus; Stents; Taxoids | 2002 |
FDA and industry happenings.
Topics: Coronary Stenosis; Drug Approval; Humans; Stents; Taxus; United States; United States Food and Drug Administration | 2006 |
Simultaneous restenosis of Taxus and Cypher drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Cardiac Catheterization; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Cyperus; Drug Delivery Systems; Equipment Failure; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Plant Preparations; Recurrence; Retreatment; Risk Assessment; Severity of Illness Index; Stents; Taxus; Treatment Outcome; Vascular Patency | 2006 |